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Abstract 
During infection, Mycobacterium tuberculosis encounters hostile conditions which 
result in the generation of host-derived reactive oxygen (ROS) and nitrogen species 
(RNS) as part of the immune response to control the infection. Exposure to these 
reactive radicals can lead to oxidative damage of DNA, which ultimately destabilises 
the genome and introduces mutations. However, M. tuberculosis is well equipped 
with a number of DNA repair pathways such as the base excision repair (BER) 
pathway, which plays a role in maintaining genome stability and survival of the 
pathogen. A number of DNA glycosylases are involved in the BER pathway, 
including formamidopyrimidine (Fpg), endonuclease VIII (Nei) and endonuclease III 
(Nth), which are the initial enzymes responsible for recognition and excision of 
damaged DNA bases. It was previously demonstrated that combinatorial deletion of 
nth and two nei homologues in Mycobacterium smegmatis resulted in reduced 
survival under oxidative stress conditions with a corresponding increase in mutation 
rates, suggestive of interplay between these enzymes. To understand the molecular 
basis of this interplay, the individual effects of the Nei homologues (NeiI and NeiII), 
together with Nth on survival and mutagenesis under oxidative stress conditions, 
expected to induce DNA damage, were investigated in the current study. Two 
mutants lacking nth and either neiI or neiII were generated by homologous 
recombination. These double deletion mutants together with the individual deletion 
mutants, the parental strain and the respective complemented strains were 
phenotypically characterized under oxidative stress conditions and assessed for 
increased mutagenesis as measured by rifampicin resistance. Defects in the BER 
system resulted in reduced survival under oxidative stress conditions. Deletion of nth 
combined with the neiII homologue led to reduced survival under oxidative stress 
conditions and an increase in spontaneous mutagenesis to rifampicin when 
compared to the deletion of nth combined with the neiI homologue. Collectively these 
data suggest that NeiII may play an important physiological role in BER in 
comparison to the NeiI homologue.   
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1. Introduction 
1.1 Tuberculosis 
Tuberculosis (TB), caused by Mycobacterium tuberculosis, is one of the oldest recorded 
human diseases, and is still one of the biggest killers among the infectious diseases, 
despite the worldwide use of a live attenuated vaccine and several antibiotics. M 
tuberculosis is primarily transmitted through inhalation of aerosol droplets expelled by 
infected hosts.  
 
TB is spread from person-to-person through the air by droplet nuclei which are produced 
when persons with pulmonary or laryngeal TB cough and sneeze (Schaaf and Zumla, 
2009). Droplet nuclei can also be generated during aerosol treatments, sputum induction, 
aerosolization during bronchoscopy, and through manipulation of lesions or processing of 
tissue or secretions (Mlambo, 2004). Due to their small size, droplet nuclei can remain 
airborne for minutes to hours after expectoration (Nardell, 2004). When inhaled, droplet 
nuclei are carried down the bronchial tree and implant in respiratory bronchioles or alveoli in 
the lungs. Whether or not an inhaled tubercle bacillus establishes an infection in the lung 
depends on both bacterial virulence and the inherent microbicidal ability of the alveolar 
macrophage that ingests it (Dannenberg, 1989, Schaaf and Zumla, 2009). The last two 
decades has seen a dramatic rise in drug resistant TB, with composite forms of resistance 
that are difficult to treat. Hence, new vaccines and drugs are needed to stem the worldwide 
epidemic of TB. To rationally develop new anti-tubercular agents, it is essential to study the 
genetics and physiology of M. tuberculosis and related mycobacteria. It is equally important 
to understand the M. tuberculosis-host interaction to learn how these bacteria overcome 
host defences and cause disease (Smith, 2003). 
 
Worldwide almost 8.7 million cases of TB occur every year and cause about 1.4 million 
deaths each year (Glaziou et al., 2013). The recent data obtained in 2015 surveillance 
shows that India has the highest incidence rate of 2.0 million–2.5 million, followed by China 
with 0.9 million–1.1 million (WHO, 2016). South Africa is in third position with an incidence 
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rate of approximately 0.4 million–0.6 million annually and countries such as Indonesia and 
Pakistan account for 0.4 million–0.5 million and 0.3 million–0.5 million cases respectively 
(WHO, 2015). TB accounts for extraordinarily high rates of morbidity and mortality 
worldwide primarily because of its ability to persist for long periods of time in the face of an 
active immune response, and to adapt rapidly to the changing conditions inside and outside 
the host (Ulrichs and Kaufmann, 2002, zu Bentrup and Russell, 2001).  
 
M. tuberculosis and HIV have been closely entwined since early years of the HIV/AIDS 
pandemic. They individually carry the risk of creating social, economic and political 
instability. The overwhelming burden of disease due to both HIV and TB is borne by 
resource –limited countries and the hardest hit among these is sub-Saharan Africa. In sub-
Saharan Africa the HIV epidemic is accelerating together with the already massive TB 
epidemic. TB is now the leading cause of death among HIV positive patients. HIV increases 
the risk of reactivation of latent TB (LTBI) and progression to active TB disease more than 
other risk factors. In some countries, the percentages of patients with active TB who are co 
infected with HIV are now greater than 60% (WHO, 2015), even with appropriate 
management of TB. Patients with HIV co-infection have increased mortality as a 
consequence of HIV related complications (Corbett et al., 2003). 
 
TB/HIV co-infection represents a novel pathogenic scenario at the global level. It constitutes 
a serious diagnostic and therapeutic challenge and, particularly in poor countries, where it 
weighs heavily on already strained health care budgets. There is growing appreciation that 
the epidemiology, clinical manifestations, and management of both HIV and M. tuberculosis 
infections are different and far more complex in co-infected compared to mono-infected 
patients. However, our knowledge about the mechanisms of interaction of the two 
pathogens still has many gaps that need to be filled in order to develop preventive 
measures against the two diseases (Pawlowski et al., 2012). Despite the epidemiological 
data supporting the notion that M. tuberculosis infection has a negative impact on the 
immune response to HIV and on progression to AIDS, research on possible mechanisms is 
scarce. The function of many immune cells, including macrophages and dendritic cells 
(DCs), is modulated by both HIV and M. tuberculosis infection (Pawlowski et al., 2012).  
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The primary target for M. tuberculosis, the alveolar macrophage, can also be infected with 
HIV (Padayatchi et al., 2017). Mycobacteria exacerbate HIV replication in macrophages and 
lung cells obtained by broncho-alveolar lavage from co-infected individuals. Also, in vitro 
studies have demonstrated that M. tuberculosis infection can up-regulate both HIV infection 
and replication within monocyte-derived macrophages (MDMs), increase the efficiency of 
virus transmission from infected MDMs to T cells, and favour replication of X4 HIV variants 
by up-regulation of CXCR4 (Adu, 2014). Furthermore, monocytes from HIV+ patients display 
an impaired response to toll-like receptors (TLR) ligands, and viral proteins, which can 
interfere with both MDM and dendritic cell (DC) maturation and function in vitro, including 
their ability to phagocytose mycobacteria and kill intracellular bacteria (Pawlowski et al., 
2012). SOCS1, which is stimulated by infection with M. tuberculosis, has been shown to 
facilitate the late replication pathways of HIV infection and mediate viral evasion of type I 
interferon (IFN) anti-viral signalling (Fenner et al., 2006). While tumour necrotic factor (TNF) 
production in response to M. tuberculosis infection is required for control of bacterial growth, 
TNF is known to activate HIV replication in macrophages, indicating that the host immune 
response initiated against one pathogen may promote the replication of another. Thus, both 
HIV and M. tuberculosis stimulate TNF release from infected cells, and TNF hampers 
bacterial growth while enhancing HIV replication (Pawlowski et al., 2012). 
 
It is estimated that approximately 1.1 million incident cases, of the 8.7 million people who 
developed TB infection worldwide, were HIV positive (Gao et al., 2013, WHO, 2015). In 
Africa TB co-infection with HIV cases are high (WHO, 2015). South Africa accounts for 28% 
of the world’s HIV-related TB cases (Corbett et al., 2003). Another serious problem 
associated with HIV infection is that it allows for the dissemination of bacilli, which leads to 
the development of extra-pulmonary TB (EP-TB) (Caws et al., 2008). The diagnosis of TB in 
HIV infected individuals and EP-TB are challenging considering the fact that with EP-TB, the 
number of bacilli are usually low in the tissues at sites of the disease and another difficulty is 
in obtaining clinical specimens from deep-seated organs (Prihoda et al., 2008). At least one-
third of HIV patients are more prone to TB, however, antiviral agents play an important role 
in the effectiveness of TB treatment (Sun et al., 2016). 
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1.2 Treatment of TB infection 
Infection with M. tuberculosis can result in active TB or more commonly, latent infection, 
which is defined as having evidence of M. tuberculosis infection by immunologic tests 
(tuberculin skin test [TST] or IFN-γ release assay [IGRA]) without clinical signs or symptoms 
of disease and a normal chest radiograph (Organization and Initiative, 2010). This 
represents a state of equilibrium in which the host is able to control the infection but not 
completely eradicate the bacteria. Patients with latent infection are the largest reservoir for 
potential transmission. Although most patients with latent infection will not die of TB, the 
greatest danger is in reactivation (active TB after Latent TB infection [LTBI]) cases and the 
subsequent silent spread to close contacts. The latent stage is normally tolerant to multiple 
anti-TB drugs therefore, rendering a need to discover and develop TB drugs and drug 
regimens that are well understood and superior to those available today in their efficacy, 
speed of action, safety and tolerability, ease of use for all patient populations, and 
accessibility. 
The standard treatment regimen for drug-susceptible TB includes an intensive phase 
consisting of rifampin, isoniazid, and pyrazinamide, to which ethambutol is added as 
protection against unrecognized resistance to one of the three core drugs. Once 
susceptibility to isoniazid, rifampin, and pyrazinamide has been confirmed, ethambutol can 
be discontinued (Parumasivam et al., 2016). In young children, this drug is frequently 
omitted if the source of transmission is known to have drug-susceptible TB, because 
recognizing the toxic effects of ethambutol is challenging in children. The intense phase is 
followed by a continuation phase consisting of rifampin and isoniazid for an additional 4 
months of treatment (Parumasivam et al., 2016).  
The standard 6-month treatment regimen for drug-susceptible tuberculosis is an 
exceptionally long course of treatment as compared with the duration of treatment of other 
bacterial infectious diseases (Albanna et al., 2011). The prolonged regimen poses two 
major challenges to success: managing drug toxicity and ensuring that patients adhere to 
the full course of treatment. Drug toxicity is substantial; a review of retrospective studies 
using similar definitions estimates that 3 to 13% of patients have hepatotoxic effects 
(Saukkonen et al., 2012). A recent prospective cohort study of patients with drug-
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susceptible disease who received standard tuberculosis therapy documented a 15% 
incidence of adverse drug reactions resulting in interruption or discontinuation of one or 
more of the drugs. Of these adverse reactions, 7.7% resulted in hospitalization, disability, or 
death. A wide variety of reactions were reported; the most common were hepatotoxic 
effects, gastrointestinal disorders, allergic reactions, and arthralgia (Lv et al., 2013).  
Multidrug-resistant (MDR) tuberculosis, is defined as the disease caused by M. tuberculosis 
that is resistant to both rifampin and isoniazid (Gunther et al., 2015). Recommendations for 
the treatment of drug resistant tuberculosis comprise a regimen consisting of a rifamycin, 
ethambutol, and pyrazinamide, with or without a fluoroquinolone, for 6 to 12 months (Allan, 
1977). However, it can be difficult for patients to complete 9 months of treatment with an 
injectable agent. Eighteen-month regimens comprising isoniazid, pyrazinamide, and 
ethambutol, with or without a fluoroquinolone, are also recommended, on the basis of 
clinical experience. If the isolate is susceptible to isoniazid and pyrazinamide, a shorter and 
less toxic regimen can be used. For MDR tuberculosis, all the national guidelines surveyed 
recommend regimens that are individualized on the basis of the results of drug-susceptibility 
testing (WHO, 2016). In order to control the drug resistance epidemic it is necessary to gain 
insight into how M. tuberculosis develops drug resistance. This knowledge will help to 
understand how to prevent the occurrence of drug resistance as well as identifying genes 
associated with resistance to new drugs. 
The various anti-mycobacterial agents have varying mechanisms of action (see Figure 1.1) 
(Kimerling et al., 2008). The molecular mechanisms which are responsible for isoniazid 
(INH) resistance are quite complex as they have been associated with a variety of mutations 
which affect one or several genes involved in mycolic acid biosynthesis (Figure 1.1) 
(Johnson et al., 2006). Genes which are associated with INH resistance are katG, inhA, and 
ahpC; however, the more frequent mutation in INH resistant isolates is located in codon 315 
of KatG. Mutation in the katG gene is responsible for 60-70% of isoniazid-resistant strains 
(Johnson et al., 2006, Miesel et al., 1998). 
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Rifampicin (RIF) is known to interfere with transcription in bacteria by binding to the β-
subunit of RNA polymerase (the product of the rpoB gene). Mutations in codons 516, 526 
and 531 of rpoB are most commonly associated with high-level RIF resistance, especially in 
the areas with high incidence of MDR-TB, but the frequency with which these mutations are 
observed, varies by geographic location and treatment history (Ramaswamy and Musser, 
1998, Cavusoglu et al., 2002, Van Deun et al., 2009), in addition mutations in this region 
causes cross-resistance to rifamycins (Palomino, 2009). Of all RIF resistance mutations, 95 
to 98% are found in an 81 bp ‘hotspot’ called the RIF resistance-determining region 
(RRDR), codons 507 to 533 (Telenti et al., 1993, Gillespie, 2002).  The point mutation that 
occurs in the rpoB gene in codons 511-533 accounts for approximately 90% of RIF resistant 
Figure 1.1: Cellular components targeted by the first line anti-TB drugs In this 
illustration, Pyrazinamide, Isoniazid, Rifampicin and Ethambutol are drugs that target 
different pathways that are essential for the survival of M. tuberculosis [adapted from 
(Shi et al., 2007)]. 
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M. tuberculosis strains from different countries (Nunn and Tweed, 2016). Ninety-five percent 
of M. tuberculosis strains with resistance to RIF contain distinct mutations located within 81 
bp (27 codon) region of the β-subunit of the RNA polymerase (rpoB) gene (Palomino, 2009). 
RIF resistance have also been reported to be caused by mutations in other parts of rpoB 
outside the hot spot region, such as codon 176 (146) in the N-terminal part and codons 541 
and 553  (Telenti et al., 1993).  
RIF remains a major drug used in the treatment of TB infections, and an increased RIF 
resistance worldwide, represents a global clinical problem. Resistance to anti-TB drugs is 
mostly due to inadequate chemotherapy and poor clinical management, which results in the 
selection of resistant isolates. RIF’s mono-resistance is extremely rare and as a result, 
resistance to RIF has been a surrogate marker for MDR-TB (Gillespie, 2002).  
The result of drug susceptibility testing (DST) is the critical component of initiating treatment 
when infection is detected. There has been a marked increase recently in the development 
of both phenotypic and molecular assays to detect M. tuberculosis complex (Gagneux and 
Small, 2007). DST for certain drugs can also be technically challenging and in resource-
limited areas, cost prohibitive. The use of molecular methods to identify mutations 
associated with drug resistance can decrease diagnostic delay and, in some cases, may 
prove to be more useful than phenotypic DST.  
In 2010, South African Department of Health rolled out the line probe assay (LPA) 
(GenoType MTBDRplus, Hain Life Science) nationwide for the rapid detection of drug 
resistance and thereby tailoring of treatment regimens. However, rapid methods are not a 
replacement for culture, most are not reliable when used with smear-negative specimens. 
Conventional DST is not sensitive enough whilst the specificity of LPA is high (Williamson et 
al., 2011). Discordant results with the BACTEC Mycbacteria Growth Indicator Tube (MGIT) 
960 and LPA have been widely observed nationally since the rollout of the rapid LPA 
(Parsons et al., 2011). Approximately half of MDR suspects screened by LPA (GenoType 
MTBDRplus, Hain Life Science) that had neither wild type nor high level mutations bands 
were susceptible by MGIT (Parsons et al., 2011). The cause of discordance between 
molecular and phenotypic DST may include human error or laboratory error, unknown 
mechanisms of resistance, rpoB mutations due to fitness loss that results in false 
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susceptible phenotypic DST, limited genes and sites targeted in the assays, emerging 
resistance and/or mixed populations, not all mutations are associated with phenotypic 
resistance, silent mutations that leads to no change in protein, neutral polymorphisms (e.g., 
gyrA codon 95 may be Ser or Thr), and phenotypic DST mutations which may result in 
elevated minimal inhibitory concentrations (MIC) but susceptibility at critical concentrations 
for DST (e.g., Leu511Pro in rpoB) (Van Deun et al., 2009, Williamson et al., 2011). In DST 
proficiency testing among the Supranational Reference Laboratories, 10% of the strains 
yielded less than 80% agreement for Rif resistance, leading to exclusion of these strains 
from a judicial result. DNA sequencing of these strains showed the presence of particular 
rpoB gene mutations despite their variable susceptibility. Further investigation of these 
strains showed that 85% of the strains classified as resistant or probably resistant strains 
(on the basis of mutations in the rpoB gene and poor treatment outcome), yielded 
susceptible results by the rapid BACTEC MGIT 960 or radiometric method (Williamson et 
al., 2011). 
Susceptible MGIT results from genotypically RIF-resistant strains have been reported in the 
literature. A recent retrospective study conducted in New Zealand showed that 4.3% of 
phenotypically INH-resistant, RIF-susceptible strains harboured clinically significant rpoB 
mutations and had led to treatment failure (Parsons et al., 2011). These variable strains with 
low-level resistance, linked to specific rpoB mutations, thus seem to have clinical relevance 
(occult MDR-TB). They may also not be so rare, representing around 15% of all rpoB 
mutations found in primo-treatment failures and relapses from Bangladesh and Kinshasa 
(Van Deun et al., 2013). The frequency of these mutations in different geographical settings 
is not known and should be assessed. There are two important issues related to these 
mutations, their effect on sensitivity of DST for RIF by BACTEC MGIT 960, widely used in 
several countries and their impact on clinical outcome of TB.  
 
1.3 Pathogenesis 
Infection of tuberculosis is initiated by inhalation of droplet nuclei, which are particles of 1–5 
μm in diameter containing M. tuberculosis, expectorated by patients with active pulmonary 
TB (open TB), typically when the patient coughs. The droplet nuclei, due to their small size, 
can remain suspended in the air for several minutes to hours (Figure 1.2). The risk of 
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infection is dependent on several factors such as the infectiousness of the source case, the 
closeness of contact, the bacillary load inhaled, and the immune status of the potential host 
response (Zhang, 2005) . 
 
The primary route of infection involves the lungs. Inhaled droplet nuclei avoid the defences 
of the bronchi due to their small size and penetrate into the terminal alveoli (Figure 1.2 B) 
where they are engulfed by phagocytic immune cells (macrophages and dendritic cells). M. 
tuberculosis can also infect non-phagocytic cells in the alveolar space including M cells, 
alveolar endothelial, and type 1 and type 2 epithelial cells (pneumocytes) (Abebe et al., 
2007) (Figure 1.2 C). 
  
In the early phase of infection, M. tuberculosis, internalized by phagocytic immune cells, 
replicates intracellularly and the bacterially loaded immune cells may cross the alveolar 
barrier to cause systemic dissemination (Zhang, 2005). The intracellular replication and 
simultaneous dissemination of the pathogen to the pulmonary lymph nodes and to various 
other extra-pulmonary sites occurs prior to the development of the adaptive immune 
response. This exemplifies the extraordinary ability of M. tuberculosis to establish a 
protected niche where it can avoid elimination by the immune system and persist indefinitely 
(Cooper, 2009). In the vast majority of the infected individuals, an effective cell-mediated 
immune response develops 2–8 weeks after infection that stops further multiplication of the 
tubercle bacilli. The activated T lymphocytes, macrophages, and other immune cells form 
granulomas (Figure 1.2 D) that wall off the growing necrotic tissue limiting further replication 
and spread of the tubercle bacilli.  
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Most of the M. tuberculosis is killed in the caseating granulomas, and disease progression is 
arrested. However, the pathogen is not completely eradicated in some individuals as M. 
tuberculosis has evolved effective strategies to evade the immune response resulting in 
survival and persistence of some bacilli in a non-replicating state in the host (Al-Harbi, 
2012). In this case, that is LTBI, for reasons such as a weakened immune system; bacilli 
can start replicating inside this primary lesion, allowing for active disease to follow. 
 
 
Figure 1.2:  Life cycle of M. tuberculosis within the human host and the 
resultant formation of granuloma caseate within the lung. When M. 
tuberculosis is inhaled and gains entry into the host via phagocytosis, it persists in 
the macrophages of the lung tissues. A sub-population of the infected 
macrophages undergoes differentiation, and become filled with lipid droplets, 
referred to as foamy macrophages. M. tuberculosis eventually escapes when 
granuloma caveats, resulting in transmission to other hosts [Adapted from (Ahmad, 
2010)].  
A.
B.
C.
D.
E.
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1.4 Host cell activity in response to entry of M. tuberculosis 
The precepts of cell mediated immunity (CMI) maintain that macrophages, activated by 
interferon-gamma (IFN-ᵞ), are primary effector cells responsible for controlling intracellular 
pathogens such as M. tuberculosis (Kahn et al., 1987). An impressive array of monokines 
and cell products are produced by activated immune macrophages, and many of these have 
been implicated not only in host resistance to TB, but also in the immunopathology of this 
disease. Two of the most powerful products of activated macrophages are toxic radicals of 
oxygen and nitrogen (Nathan and Ehrt, 2004). 
From the point of granuloma formation, the mycobacteria are continuously exposed to both 
oxidative and nitrogenous stress generated by the activated macrophages that they inhabit. 
Macrophages produce ROIs (reactive oxygen intermediates) such as hydroxyl radical (•OH), 
singlet oxygen (1O2) and one-electron and reactive nitrogen species (RNS) which form part 
of the anti-mycobacterial mechanisms (Zahrt and Deretic, 2002, Cadet and Wagner, 2014). 
RNIs (reactive nitrogen intermediates) serve as cytotoxic agents in the immune response to 
pathogens. Production of these compounds by host cells appears to be essential in the 
control of mycobacterial infection. Reactive oxygen species (ROS) and reactive nitrogen 
species (RNS) are produced by two enzymes namely NADPH oxidase (NOX2/gp91phox) and 
inducible nitric oxide synthase (iNOS) respectively, from activated macrophages (Ehrt and 
Schnappinger, 2009b). The superoxide anions (O2
·−) produced by NOX2 as catalysts for the 
production of ROS species, •OH, 1O2 and hydrogen peroxide (H2O2) (Babior, 1999). The 
reactive oxygen species are formed when NOX2 assembles into an active enzyme complex 
that transports electrons across the membrane from NADPH to molecular oxygen, and 
results in the production of (O2
·−), that dismutase into H2O2 and consequently generates 
lethal hydroxyl. IFN-ᵞ induces iNOS and make nitrite along with nitrate through nitric oxide 
radicals (Ehrt and Schnappinger, 2009b). The mutagenic and cytotoxic effect of ROIs and 
RNIs is based on several chemical reactions leading to damage of cellular macromolecules 
including DNA. 
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1.5 DNA damage 
DNA in living cells is subjected to many chemical alterations. If the genetic information 
encoded in the DNA is to remain uncorrupted, any chemical changes must be corrected. A 
failure to repair DNA before it is replicated produces a mutation. Damage to DNA is induced 
by certain wavelengths of radiation, ionizing radiation and ultraviolet rays, highly-reactive 
oxygen radicals, chemicals in the environment, and chemicals used in chemotherapy of 
cancers. Various forms of DNA damage arise from exposure to endogenous and exogenous 
DNA damaging agents. All four of the different bases in DNA (A, T, C, and G) can be 
covalently modified at various positions. One of the most frequent base modifications is a 
deamination, i.e. a loss of an amino group. Mismatches of DNA bases can arise because of 
a failure of proofreading during DNA replication. DNA strand breaks from ionizing radiation 
or chemicals can be limited to one of the two strands giving rise to a single strand break 
(SSB), or on both strands causing a double strand break (DSB). Crosslinks or covalent 
linkages, induced by several chemotherapeutic drugs, can be formed between bases on the 
same DNA strand (intra-strand breaks) or on the opposite strand (inter-strand breaks). 
 
1.5.1 Endogenous Stresses 
1.5.1.1 Hydrolytic DNA damage 
Endogenous DNA lesions are caused by chemical hydrolysis of nucleoside bases or by 
reaction of DNA with electrophiles or reactive free radicals generated during metabolism. 
Uracil (U) is normally confined to RNA, but it can arise in DNA by replication error and by 
spontaneous deamination of cytosine (Figure 1.3 C) (Mosbaugh, 1988). Uracil in DNA is 
subject to removal by Uracil DNA glycosylase (UDG or Ung)-initiated base excision repair 
(BER). Spontaneous deamination of 5-methylcytosine (5-meC) generates thymine (T) 
leading to T:G mis-pairs (Figure 1.3 B), which is a major cause of mutations in eukaryotes 
(Ehrlich et al., 1990). Adenine (A) and guanine (G) can also deaminate albeit with a lower 
rate creating hypoxanthine and xanthine respectively (Figure 1.3 A & D). Hypoxanthine is 
potentially mutagenic, mis-pairing with C during DNA replication (Batey, 2004). Xanthine, on 
the other hand, is only able to pair with C or T unstably, which may arrest DNA synthesis 
(Greer and Zamenhof, 1962). Furthermore, the N-glycosylic bond of DNA, particularly with 
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purine residues, is susceptible to spontaneous hydrolysis resulting in an 
apurinic/apyrimidinic site (APsite) (Lindahl and Barnes, 2000).  
 
 
 
 
 
1.5.1.2 Oxidative DNA damage 
Reactive oxygen species (ROS), such as superoxide, hydrogen peroxide (H2O2), and 
hydroxyl radicals, which are generated during normal cellular metabolism and by 3 external 
sources, such as UV light, ionizing radiation and some chemicals, can lead to various types 
of DNA damage, including oxidized or ring-opened base lesions, abasic sites and strand 
breaks (Cheng, 1992). Common oxidative base lesions are shown in Figure 1.4. Oxidative 
damage is generally repaired by the base excision repair (BER) pathway. Guanine (G) has 
a low redox potential thus making it particularly vulnerable to oxidation (Cooke, 2003). One 
of the most abundant oxidized base lesions is 7, 8-dihydro-8-oxo-2’-deoxyguanosine (8-
oxoG), Figure 1.4. 8-oxoG is a major form of mutagenic base damage, which can mispair 
with adenine (A) during replication, giving rise to G to thymine (T) transversions (Cheng, 
1992). The ring opened purine derivatives, 2,6-diamino-4-hydroxy-5-formamidopyrimidine 
(FapyG) and 4,6-diamino-5-formamidopyrimidine (FapyA) are generated by H2O2 treatment, 
as well as ionizing radiation (Kim and M Wilson III, 2012).  
Figure 1.3: Hydrolytic DNA lesions. 
DNA damaged lesions that arise from deamination of Adenine; Cytosine, Guanine and 5’-
methylcytosine (Gates, 2009). 
A. 
D. 
B. 
C. 
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1.5.2 Exogenous stress 
1.5.2.1 Alkylation damage 
Alkylating agents are electrophilic compounds which can attack nucleophilic centres of DNA 
resulting in N-alkylated or O-alkylated purines and pyrimidines as well as phosphotriesters 
(Sinha and Hader, 2002). The most abundant alkylation products in double-stranded DNA 
are 7-methylguanine and 3-methyladenine, both of which block DNA replication and thus 
are cytotoxic. Other alkylation products, such as O6-methylguanine and O4-methylthymine 
can mispair during DNA replication resulting in mutagenesis. The O6-alkylated guanine 
lesions can be directly reversed to guanine; the other alkylated bases are repaired by the 
BER pathway (Sancar et al., 2004). 
 
Figure 1.4: Oxidative DNA Lesions 
DNA damaged lesions that arise from oxidation of adenine; cytosine, guanine and 
cytosine (Marnett, 2000). 
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1.5.2.2 Ionizing Radiation-induced Damage 
Ionizing radiation, including α-particles, β-particles, X rays and γ-rays, damage DNA by 
direct deposition of radiation energy (direct effect) and more commonly by ionization of 
water molecules to produce hydroxyl radicals (indirect effect), thus inducing multiple forms 
of DNA damage, including base lesions, AP sites, single-strand breaks (SSBs) as well as 
double-strand breaks (DSBs) (Ward, 1973). The damage generated by radiation-induced 
hydroxyl radicals overlaps considerably with those generated during normal oxidative 
metabolism, which is efficiently removed by BER. A special feature of ionizing radiation is 
the formation of clustered damage or multiple damage sites in close proximity on the DNA 
(Cadet, 2016). Clustered damage on the opposite strands of DNA can readily cause DSBs, 
which are among the most cytotoxic and mutagenic lesions. DSBs are repaired by 
recombinational repair (Cadet, 2016). 
 
1.5.2.3 UV induced damage 
UV-induced DNA damage can result from the direct absorption of photons by DNA. The 
most frequent DNA lesions formed by UV radiation are cyclobutane pyrimidine dimers 
(CPD) and pyrimidine-pyrimidone (6-4) photoproducts [(6-4) PP] wherein two adjacent 
pyrimidines are covalently linked. Moreover, UV radiation results in DNA-protein cross-links 
and occasionally inter-chain DNA-DNA cross-links (Drabla¸s et al., 2004). These 
photoproducts, as well as other minor photoproducts in DNA, can interfere with DNA 
replication and transcription. Both CPD and 6-4 PP can be excised from DNA by the 
nucleotide excision repair pathway (NER). UV radiation can also form reactive oxygen 
species causing oxidative damage (Sinha and Hader, 2002). There are two photoproducts, 
both of which are di-pyrimidine structures, believed to be responsible for most of the 
carcinogenic effects of UV radiation. These two photoproducts, cyclobutane pyrimidine 
dimer (CPD) and 6-4 pyrimidine –pyrimidone, are caused by exposure to UV-B radiation. 
CPD is more common than 6-4 pyrimidine-pyrimidone and is thought to account for 
approximately 85% of primary lesions in UV-irradiated DNA. The photoproducts interfere 
with DNA replication if not repaired and cause specific mutations in DNA. The specific 
mutations induced by UV-B in DNA sequences most often include single-base substitutions 
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of cytosine (C) for thymine (T). Double-base changes from CC to TT also occur, but in an 
order of less magnitude (Cooke, 2003).  
 
1.6 DNA repair pathways 
DNA repair can occur by one of two mechanisms that involves either the reversal of DNA 
damage or the excision of the damaged bases. With regards to excision repair, three basic 
repair pathways have evolved to prevent the cytotoxic or mutagenic outcomes of DNA 
damage thus maintaining genomic integrity. BER predominantly copes with small lesions 
resulting from oxidation, alkylation or deamination, mismatch repair (MMR) corrects 
mismatches as well as insertion/deletion loops formed during replication, and nucleotide 
excision repair (NER) removes bulky helix-distorting lesions. In addition, recombinational 
repair is crucial for repairing DSBs. Moreover, in some bacteria, the physiological responses 
to DNA damage are under the control of an SOS regulatory network, which leads to not only 
DNA repair but also to damage tolerance and mutagenesis (Dos Vultos et al., 2009). 
The G/C content of the M. tuberculosis genome is very high (65.4%), making the pathogen 
particularly susceptible to guanine and cytosine oxidation and cytosine deamination 
(O'Sullivan et al., 2005). Oxidative stress plays an important role in the host’s innate 
immune response. Macrophages generate ROS and RNS resulting in lethal damage to the 
DNA of pathogenic microorganisms. However, M. tuberculosis manages to survive and 
replicate in its host’s macrophages. Therefore, the ability to repair DNA damage caused by 
exposure of the microbe to the environment within macrophages is likely to play a 
particularly important role in pathogen proliferation or colonization conferring a virulence 
advantage for M. tuberculosis (Master et al., 2008). 
 
1.6.1 Mismatch repair 
The M. tuberculosis response to DNA damage has distinguishing features compared to 
some other bacteria. Most strikingly, the genome sequences of M. tuberculosis, 
Mycobacterium leprae, and M. smegmatis indicate that these microbes lack the mismatch 
repair (MMR) homologues (Dos Vultos et al., 2009, Mizrahi and Andersen, 1998). The 
deficiency of MMR possibly confers a selective advantage under certain stressful situations 
such as the consequent increase in mutation rate, which may serve as a starting point for 
  
17 
 
the evolution of antibiotic resistance, fitness for survival and pathogenicity, and allowing 
adaptation during specific periods of the life cycle (Eisen and Hanawalt, 1999). A similar 
mismatch repair deficiency was observed for Helicobacter pylori (H. pylori), suggesting that 
the absence of MMR allows for increased mutation frequencies, emergence of antibiotic 
resistance and fitness for survival and pathogenesis under certain stressful situations (Kang 
and Blaser, 2006).  
 
1.6.2 Recombination repair 
DNA damage is a fact of life for bacteria as a consequence of endogenous sources and 
processes as well as exogenous stresses. Homologous recombination (HR) is a DNA 
metabolic process found in all forms of life that provides high-fidelity, template-dependent 
repair or tolerance of complex DNA damages including DNA gaps, DNA double-stranded 
breaks (DSBs), and DNA inter-strand crosslinks (ICLs). In addition to its role in preserving 
the genome, HR plays a prominent role in faithfully duplicating the genome by providing 
critical support for DNA replication and telomere maintenance (Boshoff et al., 2003). 
Homologous recombination repair involves the exchange of two complementary strands of 
DNA. This repair system relies on a homologous chromosomal copy as template for DNA 
synthesis and hence is considered not to be an error prone system; (Warner & Mizrahi, 
2011). The RecBCD complex is made up of a helicase and nuclease proteins that unwinds 
double stranded DNA into single strands, which are cut at a specific nucleotide sequence 
known as the Chi site (Kowalczykowski et al., 1994). The single stranded DNA is bound by 
the RecA protein that acts as a signal to induce the SOS response; in particular the 
RuvABC complex, which searches for homologous duplex DNA (Kowalczykowski et al., 
1994). Upon recognition of homologous DNA, RecA coated single stranded DNA invades 
the duplex recipient DNA (Kowalczykowski et al., 1994, Warner and Mizrahi, 2011). One of 
the recipient strands forms a bulge which is cleaved by the endonuclease from the RuvABC 
complex (Kowalczykowski et al., 1994). The complex then exchanges the strands which 
form a structure known as a holiday junction, followed by the ligation of swapped strands 
(Kowalczykowski et al., 1994). 
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The two homologous recombinational (HR) pathways, RecBCD and RecFOR, are present in 
M. tuberculosis. Both provide single-stranded DNA for RecA binding. The expression of 
ruvA and ruvC are up regulated upon DNA damage in M. tuberculosis (Boshoff et al., 2003). 
Taken together with previous observations that RuvC is important for the survival of 
Helicobacter pylori in macrophages (Loughlin et al., 2003), the data suggest that HR 
involving RuvC may also play an important role in repairing damage in M. tuberculosis 
(Brooks et al., 2001). Although RecJ is missing in M. tuberculosis, the expression of 
mycobacterial recR was shown to be up regulated upon capreomycin treatment, and both 
recR and recF are up regulated upon translational inhibition (Boshoff et al., 2003) 
suggesting that the RecFOR pathway is active in M. tuberculosis. The NHEJ pathway was 
once thought to be restricted to eukaryotes but was also identified in prokaryotes. The 
process in M. tuberculosis is aided by the DNA end binding protein Ku homo dimer and 
DNA ligase D (LigD) (Shuman and Glickman, 2007). The physical interaction between 
mycobacterial Ku and LigD stimulates the ligase activity of LigD on DSBs (Shuman and 
Glickman, 2007). Deleting Ku or LigD significantly lowers the efficiency of NHEJ-directed 
DSBs repair in mycobacteria (Shuman and Glickman, 2007). Moreover, M. tuberculosis 
contains a LigD-independent NHEJ pathway in which LigC may function redundantly in 
NHEJ. The absence of NHEJ sensitizes mycobacteria to desiccation and ionizing radiation 
(Rassool, 2003). NHEJ may be the only pathway available to repair DSBs during LTBI, 
assuming that no daughter chromatid is present for HR. NHEJ may also be important for 
repairing DSBs induced by clustered oxidative damages within macrophages and promoting 
the survival of the pathogen (Dos Vultos et al., 2009, Shuman and Glickman, 2007).               
                                                                  
1.6.3 Nucleotide excision repair 
Nucleotide excision repair (NER) identifies and removes bulky DNA lesions generated from 
UV irradiation and genotoxic compounds (Friedberg and Gerlach, 1999, Kurthkoti and 
Varshney, 2011, Kurthkoti and Varshney, 2012,). This repair pathway executes its function 
using several Uvr proteins (Muir et al., 1998). The Uvr proteins have low base specificity 
and act in combination, usually forming a complex because they remove multiple lesions. 
UvrA and UvrB identify and bind to the DNA lesion forming a UvrAB complex (Kurthkoti and 
Varshney, 2011, Kurthkoti and Varshney, 2012). UvrA is released when UvrC binds to UvrB. 
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The UvrBC complex cleaves and excises the surrounding upstream and downstream 
regions of the DNA damage (Sancar, 1996). Thereafter, UvrD removes the UvrBC complex 
with the lesion and the surrounding regions including 12-13 nucleotides which creates a gap 
(Kurthkoti and Varshney, 2011, Kurthkoti and Varshney, 2012). The gap is filled by DNA 
polymerase and ligase (Kurthkoti and Varshney, 2011, Sancar, 1996). In M. tuberculosis the 
uvrB gene is essential in vivo (in mice) for infection and in vitro (human macrophages) for 
survival (Darwin and Nathan, 2005). M. tuberculosis possesses two homologues of UvrD 
proteins - UvrD1 and UvrD2 (Cole et al., 1998, Mizrahi and Andersen, 1998). UvrD1 is a Ku 
dependent protein and is bi-functional (Guthlein et al., 2008). It has helicase and DNA-
dependent ATPase activities that allow this protein to repair double and single strand breaks 
(Guthlein et al., 2008, Sinha and Hader, 2002). Hence, UvrD1 can function within NER and 
non-homologous end joining repair (Kurthkoti and Varshney, 2011,  Shuman and Glickman, 
2007). UvrD2 on the other hand is a helicase specific to NER that is essential for M. 
tuberculosis survival when exposed to UV irradiation (Boshoff et al., 2003, Kurthkoti and 
Varshney, 2011). 
 
M. tuberculosis possesses all the genes involved in the NER pathway. The expression of 
uvr genes is enhanced in intracellular M. tuberculosis demonstrating the importance of NER 
for the pathogen’s survival upon infection (Thi et al., 2012). In addition, these genes are also 
involved in damage caused by  H2O2  and are up regulated upon UV exposure (Friedberg et 
al., 2005). Mutants lacking uvrB were highly susceptible to acidified nitrite and UV light and 
were markedly attenuated for survival in mice and bone marrow-derived macrophages (de 
Laat et al., 1999). Moreover, M. tuberculosis has two putative genes encoding DNA helicase 
II: uvrD1 and uvrD2 (de Boer and Hoeijmakers, 2000). The Ku-dependent UvrD1 seems to 
be essential for mycobacterial repair of DNA damage caused by UV and ionizing radiation 
and is up regulated upon H2O2 treatment (Boshoff et al., 2003, Sinha and Hader, 2002). The 
absence of UvrD1 attenuates M. tuberculosis during infection (Curtiet al., 2007). On the 
other hand, UvrD2 is a Ku-independent helicase, which is also up regulated upon UV 
radiation (Boshoff et al., 2003). The potentially redundant functions of UvrD1 and UvrD2 
strongly suggest the important role of NER in M. tuberculosis. 
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1.7 Base excision repair pathway 
Base excision repair (BER) is an important multistep, multi-enzyme DNA repair system. 
BER of modified nucleotides is initiated by damage-specific DNA glycosylases, Figure 1.5. 
The repair of the resulting apurinic/apyrimidinic site (AP site) involves the replacement of 
either a single nucleotide (short patch BER) or of several nucleotides (long patch BER) 
(Kurthkoti and Varshney, 2012). The mechanism that controls the selection of either BER 
pathway is unknown. DNA glycosylases cleave the N-glycosidic bond between the target 
base and the deoxyribose, releasing a free base, thus creating an AP site.  
 
In the short patch model as shown in Figure 1.5, DNA glycosylases are the initial enzymes 
that recognize and excise damaged bases, (I). Following this an AP endonuclease cleaves 
the phosphodiester bond immediately 5´ to the AP site, generating 5´-sugar phosphate and 
3´-OH ends as it nicks the DNA (II). Removal of the 5´- sugar phosphate moiety by a 
deoxyribophosphodiesterase (dRpase) (III) results in a single nucleotide gap that is then 
filled by a DNA polymerase (IV) and sealed by DNA ligase (V). As in short patch BER, AP 
sites in long patch BER are processed by an AP endonuclease which cleaves immediately 
5´ to the AP site, generating 5´- sugar phosphate and 3´-OH ends (Kurthkoti and Varshney, 
2012). However, in this process, the 5´-sugar phosphate residue is not removed by a 
dRpase, rather a DNA polymerase adds several nucleotides to the 3´ end of the nick 
displacing the 5´- sugar phosphate as part of a single stranded flap structure. This flap 
structure is recognized and excised by flap endonuclease (FEN1) and DNA is finally ligated 
by DNA ligase. This pathway is dependent on proliferating cell nuclear antigen (PCNA), 
which presumably plays a role in loading DNA polymerase onto the DNA as well as 
stimulating the activity of FEN1 (Dos Vultos et al., 2009). 
 
Many DNA glycosylases have been discovered and isolated, and their reaction mechanisms 
and substrate specificities have been elucidated. Most of the known products of oxidative 
damage to DNA (described previously) are substrates of DNA glycosylases with broad or 
narrow substrate specificities. Some possess cross-activity and remove both pyrimidine- 
and purine-derived lesions (Boshoff et al., 2003). Overlapping activities between enzymes 
also exist. DNA glycosylases with overlapping substrate ranges provide back-up or 
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redundant functions, so that the absence of one will be compensated by another during the 
repair of a critical mutagenic lesion. The stability and correct function of the DNA is 
necessary for normal cellular functions and damage to the DNA can lead to cellular 
dysfunction, cancer and other diseases, or to cell death. Deficiencies and polymorphisms in 
DNA glycosylase-encoding genes have been shown to be related to human disease 
susceptibility (Hazra et al., 2001). 
 
 
 
 
 
 
 
 
 
 
Figure 1.5: Schematic diagram of the base excision repair pathway 
I. Oxidatively damaged DNA base is recognized and excised by DNA glycosylases (as 
shown by the red star) generating an AP (apurinic/apyrimidic) site. II. The AP 
endonuclease cleaves the sugar-phosphate backbone to generate a single strand break 
at the 3’ hydroxyl group. III. Poly nucleotide kinase and a deoxyribophosphodiesterase 
respectively, excise the 5’-terminal deoxyribose and change the 3’-terminal to a hydroxyl 
group. IV. DNA polymerase fills in the new correct DNA base and, V. DNA ligase seals 
the gap (Kurthkoti and Varshney, 2011).  
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1.9 DNA glycosylases 
DNA glycosylases fall into two general families based on structural and sequence homology 
(David and Williams, 1998). The Nth superfamily includes endonuclease III (Nth), which 
removes both oxidized pyrimidines, such as Tg, urea, DHU and formamidopyrimidines: 
FapyA and FapyG; MutY which removes A mispaired with 8-oxoG and FapyG; Ogg1 whose 
primary substrate is 8-oxoG and FapyG opposite C; and AlkA which removes alkylated 
bases. The Fpg/Nei family is defined by formamidopyrimidine DNA glycosylase (Fpg), also 
called MutM, and endonuclease VIII (Nei). Fpg has substrate specificity similar to Ogg and 
removes 8-oxoG and FapyG paired with C as well as FapyA paired with T. The hydantoin 
lesions, Gh and Sp, are also substrates for Fpg (Leipold et al., 2000). In addition to purine 
lesions, Fpg also recognizes oxidized pyrimidines such as 5-OHC, 5-hydrouracil, and 5,6-
dihydroxy-5,6-dihydroxythymine but to a much lesser extent (Saparbaev et al., 2002). Nei has 
substrate specificity similar to that of Nth, removing oxidized pyrimidines and FapyA. Gh and 
Sp lesions are also removed by endonuclease VIII (Nei) (Mitra et al., 2001). MutY and AlkA 
do not have glycosylase activities and bind the substrate to sequester it for other DNA repair 
enzymes; the other glycosylases listed above are bi-functional and exhibit lyase activity in 
addition to glycosylase activity. These DNA glycosylases exhibit redundancy with respect to 
substrate specificities; therefore the loss of a single DNA glycosylase usually does not result 
in a complete loss of repair for a specific oxidative lesion. 
 
1.10 Preliminary studies in mycobacteria that are important for the work presented in 
this dissertation 
Several studies using gene knockout strategies were conducted to assess the various roles 
and functions of the base excision repair DNA glycosylases in mycobacteria. A study 
conducted by Goosens using bioinformatics analyses identified two copies each of Fpg and 
Nei-encoding genes in M. tuberculosis as well as in its non-pathogenic relative, 
Mycobacterium smegmatis (Goosens, 2009). To understand the role of these multiple 
glycosylases in the maintenance of genomic integrity and survival of mycobacteria, the genes 
encoding the four Fpg/Nei glycosylases were individually deleted in the M. smegmatis strain 
mc2155 by homologous recombination. In addition to the four single mutants, double and 
triple Fpg and Nei glycosylase knockout mutants were generated by sequential gene 
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inactivation. Their observation was that when comparing the parental strain, the single and 
double mutants showed no variation in growth kinetics, no increased sensitivity to hydrogen 
peroxide and no increase in spontaneous mutation rates (Moolla et al., 2014). However, a 
slight increase in frequency of spontaneous C - T transition mutations was observed in 
double knockout mutants compared to the wild type and single mutant strains. The results 
suggested that these enzymes may be part of an extensive network of enzymes which 
collectively work to enhance the overall survival of M. smegmatis through the repair of 
oxidatively damaged DNA. 
 
A study conducted by Hassim et al aimed to understand the role of MutY in combination with 
the Fpg/Nei family of DNA glycosylases in mycobacteria and whether these DNA 
glycosylases display overlapping and/or compensatory functions in dealing with oxidative 
damage (Hassim et al., 2015). Using homologous recombination, the mutY gene was deleted 
in the parental and in the Fpg/Nei deficient mutant strains. Deletion of mutY together with the 
Fpg/Nei family of DNA glycosylases yielded similar in vitro growth kinetics as the parental 
strain under normal culture conditions. However, under in vitro oxidative stress conditions, 
mutY deficiency, especially in the absence of all four Fpg/Nei DNA glycosylases, resulted in a 
greater reduction in survival of the mutants, with a general increase in mutation rates. 
Consistent with these data was the significant increase in C → A and A → C mutations with 
the progressive loss of the DNA glycosylases as assessed by the spectral analysis of 
rifampicin resistant mutants. Taken together, the authors concluded that the mycobacterial 
MutY DNA glycosylase has antimutator properties and possibly has a more significant role in 
mycobacterial genome maintenance compared to the Fpg/Nei family of DNA glycosylases. 
 
Previously, it has been shown that the lack of Fpg/Nei DNA glycosylases in M. smegmatis 
resulted in no differences in growth and survival under normal and oxidative stress 
conditions, with no increase in spontaneous mutation rates as compared to the parental 
strain, suggesting that nth may also be a significant role player in mycobacterial genome 
maintenance (Moolla et al., 2014). These findings led to the study conducted by Moolla et al. 
wherein the nth gene was site specifically inactivated by homologous recombination in the 
parental M. smegmatis strain and in selected combinatorial mutant strains deficient in the 
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Fpg/Nei glycosylases (Moolla et al., 2014). Inactivation of the nth gene did not affect the in 
vitro growth of the mutant strains under normal culture conditions. Interestingly, UV induced 
DNA damage of the single nth deletion mutant resulted in a dramatic increase in mutation 
frequency that was not observed in any of the other single DNA glycosylase deletion mutants. 
The progressive loss of fpg, nei and nth genes resulted in exaggerated survival defects under 
oxidative stress. Furthermore, the subsequent deletion of nth in mutants deficient in fpg/nei 
resulted in a dramatic increase in spontaneous mutation rates and frequencies, implying that 
nth is integral for the repair of both spontaneous and induced DNA damage. These results 
indicate that the M. smegmatis nth-encoding DNA glycosylase is involved in DNA repair and 
has anti-mutator properties and that it is able to exert a combinatorial effect with the Nei 
homologues in mutation avoidance. As a result, this study highlighted a novel interplay 
between the Nth and Nei homologues in DNA damage tolerance under oxidative stress 
conditions and in spontaneous mutagenesis. 
 
1.11 Aims and objectives of the study 
As mentioned above it was previously shown in our laboratory that the Nth DNA glycosylase 
was a key enzyme of the BER pathway responsible for preventing and/or reducing mutations 
in M. smegmatis. The previous study also demonstrated that combinatorial deletion of Nth 
and Nei in M. smegmatis resulted in reduced survival under oxidative stress conditions with a 
corresponding increase in mutation rates, suggestive of interplay between these enzymes 
(Moolla et al., 2014). Hence, it was important to assess the combined role of these genes in 
maintaining mycobacterial genome integrity. In this study we aimed to highlight the 
hierarchical role of the two Nei homologues (NeiI and NeiII) in BER. The single deletion 
mutant lacking the nth gene, that were generated previously (Moolla et al., 2014, Hassim et 
al., 2015), was used to generate double mutants that lacked both the neiI and nth, as well as 
neiII and nth genes.  
 
Aim: The overall aim of this study was to further investigate the interplay between the Nth and 
NeiI/NeiII homologues through combinatorial gene deletion and subsequent characterization 
of mutant strains.  
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Specific objectives: To achieve the above-mentioned aim the following specific objectives 
were set out: 
1. Deletion of NeiI in the Nth-defective mutant using two-step allelic exchange mutagenesis.  
2. Deletion of NeiII in the Nth-defective mutant using two-step allelic exchange mutagenesis. 
3. Genomic confirmation of the resulting mutant strains using PCR and Southern blotting 
4. Genetic complementation of the mutant strains using integrating vectors to deliver single 
gene doses  
5. Confirmation of gene expression in genetically complemented strains. 
6. Characterization of the mutant and genetically complemented strains in vitro under normal 
culture conditions and under oxidative stress. 
7. Assessment of mutation rates in combinatorial mutants.  
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2. Materials and methods 
2.1 Bacterial strains, plasmids and culturing conditions 
All bacterial strains and cloning vectors used in this study are listed in Table 1.1 and 
Table 1.2 respectively. Glycerol stocks of bacterial strains were prepared in 66 % 
glycerol and stored at -80 °C. 
 
Table 1.1: Bacterial strains  
Bacterial strain Genotype Reference  
M. smegmatis 
mc2 155 
ept-1, High frequency plasmid  transformation 
mutant of mc26 
(Snapper et al., 
1990) 
∆neiI Mutant of mc2155 carrying an internal 486 bp 
deletion in neiI 
(Goosens, 2009) 
∆neiII Mutant of mc2155 carrying an internal  637 bp  
deletion in neiII 
(Goosens, 2009) 
∆nth  Derivative of M. smegmatis mc2155 containing 
an internal 570 bp deletion in nth 
(Moolla et al., 
2014) 
∆neiI ∆nth Derivative of ΔneiI carrying an internal 570 bp 
deletion in nth 
This study 
∆neiII ∆nth Derivative of ΔneiII carrying an internal 570 bp 
deletion in nth 
This study 
∆neiI ∆nth::nth Derivative of ΔneiI Δnth carrying 
pTWEETY::nth integrated at the attP phage 
attachment site 
This study 
∆neiII ∆nth::nth Derivative of ΔneiII Δnth carrying 
pTWEETY::nth integrated at the attP phage 
attachment site 
This study 
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Table 1.2: Cloning vectors  
Plasmids Characteristics Size(bp) Reference 
pGEM3Zf(+) E. coli cloning vector; amp
R; 
lacZ-alpha; oriE 
3199 
 
Promega 
p2NIL  E. coli cloning vector and 
mycobacterial suicide 
plasmid; kanR; oriE 
4753  
 
(Parish and 
Stoker, 2000) 
pGOAL19  Plasmid carrying lacZ, hyg 
and sacBg enes as a PacI 
cassette; ampR, oriE 
10435  
 
(Parish and 
Stoker, 2000) 
p2NILΔnth::pGOAL17 p2NIL suicide vector carrying 
the deleted nth gene and the 
selectable and counter 
selectable markers from 
pGOAL17, kanR; lacZ; sacB; 
oriE 
14508 (Hassim et al., 
2015) 
p2NILΔnth::pGOAL19  
 
p2NIL suicide vector carrying 
the deleted M. smegmatis 
nth gene and the selectable 
and counter selectable 
markers (hyg-lacZ-sacB) 
from pGOAL19; kanR, hygR; 
lacZ; sacB; oriE. 
14748 (Moolla et al., 
2014) 
pTWEETY Mycobacterial integrating 
vector; kanR, oriE, int 
5835 (Pham et al., 
2007) 
pTWEETY:::nth pTWEETY integrating vector 
carrying nth: kanR 
6990 (Moolla et al., 
2014) 
pSE100 E. coli-Mycobacterial shuttle 
vector carrying Pmyc1tetO; 
5538 (Ehrt and 
Schnappinger, 
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hygR 
 
2009a) 
ampR-ampicillin resistance; oriE–origin of replication in E. coli; kanR-kanamycin 
resistance; hygR-hygromycin resistance 
 
2.1.1 Bioinformatics analysis  
Various bioinformatics tools were used to identify and analyse the Nei DNA 
glycosylases in M. smegmatis and M. tuberculosis. Genome sequence data for M. 
tuberculosis was obtained from the Tuberculosis database TubercuList 
(http://genolist.pasteur.fr/TubercuList/) and for M. smegmatis from the Smegmalist 
database (http://cmr.tigr.org). 
 
2.1.2 E. coli- DH5α strains. 
E. coli cells containing plasmids were grown overnight at 37 °C in Luria-Bertani (LB) 
broth containing the appropriate antibiotics with vigorous shaking (Labcon Shaking 
Incubator). For selection on solid media, E. coli containing plasmids were grown 
overnight in a Labotec incubator at 37 °C on Luria-Bertani agar (LA) containing the 
appropriate antibiotics. E. coli strains carrying plasmids >8000 bp was grown at 30°C for 
48 hours to avoid plasmid rearrangement. 
 
The following antibiotics were used at these concentrations: 200 μg/mL Ampicillin 
(amp), 200 µg/mL hygromycin (hyg) and 50 µg/mL kanamycin (kan). For counter 
selection of clones carrying sacB, 5 % w/v sucrose was used. For confirmation of 
disruption of the lacZ cassette during cloning or identification of a clone containing the 
lacZ cassette, 40 μg/mL of 5-bromo-4-chloro-3-indolyl- α -galactosidase (X-gal) was 
used. 
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2.1.3 Mycobacterial strains. 
M. smegmatis strains, unless otherwise stated, were grown in Middlebrook 7H9 media 
supplemented with glucose salt and 0.05 % Tween or on Middlebrook 7H10 solid 
media. All culturing of M. smegmatis strains was performed in a Bio-safety Level 2 
laboratory. For selection of strains containing vectors with various selection markers, 50 
μg/mL hyg and 25 μg/mL kan was used, and for counter selection of clones carrying the 
sacB and lacZ cassettes, 2 % w/v sucrose and 40 μg/mL X-gal was included in 7H10 
plates  
 
2. 2 DNA extractions. 
2.2.1 Plasmid DNA extraction from E. coli (Sambrook et al., 1989). 
2.2.1.1 Small scale plasmid DNA extraction. 
A single colony of E. coli carrying the plasmid of interest was re-suspended in 2 mL of 
LB media supplemented with the appropriate antibiotic and grown overnight at 37 °C 
with shaking at 250 revolutions per minute (rpm). A one mL aliquot was transferred to a 
1.5 mL micro centrifuge tube and the cells harvested at 12 470 × g for 5 min. The pellets 
were re-suspended in 100 μL of Solution I (50 mM glucose, 25 mM Tris-Cl pH 8.0, 10 
mM EDTA). To this suspension, 200 μL of Solution II (1% SDS, 0.2 M NaOH) was 
added and mixed by gently inverting tubes 6-8 times. The mixture was incubated at 
room temperature for 5 min; lastly 150 μL of Solution III (3 M Potassium acetate, pH 
5.5) was added and the tubes were incubated on ice for 5 min. Thereafter, the 
suspensions were centrifuged at 12 470 × g for 5 min. The supernatants were decanted 
into a fresh 1.5 mL micro centrifuge tube containing 1 µL RNaseA (10 mg/mL) and 
incubated at 42 ˚C for 15 min. To precipitate the plasmid DNA, 600 μL of iso-propanol 
was added and the iso-propanol-DNA mixture was incubated at –20 ˚C for ~ 30 min, 
followed by centrifugation at 12 470 × g for 30 min. The iso-propanol supernatant was 
poured off gently and the pellet was washed with 1 mL of 70% EtOH and dried at 45 °C 
in a Speed Vacuum concentrator, (5301 Eppendorf). The DNA was re-suspended in 20 
– 30 μL sterile distilled water (sdH20). 
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2.2.1.2 Large scale plasmid DNA extraction. 
For large scale DNA extractions, E. coli cultures were grown in 50 mL LB, overnight with 
shaking at 100 rpm, and cells were harvested by centrifugation in a Beckmann J2-21 
centrifuge (3901 × g for 15 min at 4 °C). The DNA extraction method was as described 
above except that the solution volumes were increased as follows: 800 μL of Solution I, 
1600 μL of Solution II and 1200 μL of Solution III. 
The small scale plasmid DNA extraction protocol was followed up until the 70 % ethanol 
wash step and larger volumes of RNaseA (3 μL) and iso-propanol (800 μL) were used. 
Following the ethanol wash, pellets were dried and re-suspended in 50-100 μL of 
sdH2O.  
 
2.2.2 Chromosomal DNA extraction. 
2.2.2.1 Small scale chromosomal DNA extraction (colony boil). 
Half a colony (~10 mm diameter) of M. smegmatis was re-suspended in 50 μL of 
sdH2O. An equal volume of chloroform was added to the suspension, mixed vigorously 
and boiled at 95 ˚C for 5 min. The mixture was centrifuged at 12 470 × g for 5 min to 
separate the cell debris. The aqueous phase above the cell debris interface was 
removed into a fresh 1.5 mL micro centrifuge tube and used as DNA template in PCR 
reactions (see section 2.3.1). 
 
2.2.2.2 Large scale chromosomal DNA extraction. 
Mycobacterial chromosomal DNA was isolated using a modified 
cetyltrimethylammonium bromide (CTAB; ICN Biomedicals, Aurora, Ohio) method 
(Somerville et al., 2005). Briefly, mycobacterial cells were harvested and re-suspended 
in 500 μL TE buffer (10 mM Tris-HCl pH 8.0, and 1 mM EDTA). The cells were heat 
killed at 65 °C for 10 min to which 50 μL of lysozyme (10 mg/mL) was added and the 
suspension was incubated at 37 °C for 1 hour. A solution of 70 μL 10 % SDS and 6 μL 
proteinase K (10 mg/mL) was added followed by incubation at 65 °C for 1 hour. 
Following this, 100 μL of a 5 M solution of sodium chloride and 100 μL pre-warmed 
CTAB/NaCl mix (10 % CTAB made in 0.7 M NaCl) was added to the sample and 
incubated at 65 °C for a further 10 min. An equal volume of chloroform: isoamyl alcohol 
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(24:1 v/v) was added to remove proteins. Subsequent to centrifugation at 6168 × g for 
30 min, the aqueous phase containing the DNA was precipitated by addition of 420 μL 
iso-propanol and incubation at -20 °C for 1 hour. The DNA was pelleted by 
centrifugation (16168 × g for 20 min), washed with ice-cold 70 % ethanol, dried in a 
vacuum centrifuge and re-suspended in 50 -100 μL sdH2O 
 
2.3 DNA manipulations. 
2.3.1 Polymerase chain reaction. 
2.3.1.1 Primer design. 
Primers were designed using the online program Primer3 (http://frodo.wi.mit.edu/) which 
suggested the most appropriate primer sequences. Primers were purchased and 
synthesized from Inqaba Biotec. 
 
2.3.1.2 PCR reactions. 
For PCR reactions using FastStart Taq DNA polymerase (Thermo Scientific™), the 
reactions were set up in 50 μL volumes with the following components: 1× 
recommended buffer, 1× GC Rich solution, dNTPs to a final concentration of 0.2 mM 
each, forward and reverse primers to a final concentration of 1 μM each, DNA template 
between 10-100 ng/μL and 2 U enzyme. Reactions were made up to volume with sterile 
distilled nuclease free water.  Cycling conditions were carried out as follows: one cycle 
of an initial denaturation at 94 °C for 4 min; 30-35 cycles of 30 sec denaturation at 94 
°C, 30 sec annealing at 55-65 °C and 30-90 sec elongation at 72 °C which was followed 
by a final elongation step at 72 °C for 5-7 min. 
 
2.3.2 Restriction enzyme digestions. 
All restriction enzymes and buffers used were purchased from New England Biolabs 
(NEB) or Roche Applied Sciences. Reactions were carried out according to the 
manufactures instructions. All digestion reactions were incubated at 37 °C with the 
appropriate buffer for optimal enzyme performance. For plasmid DNA 1-2 μg was 
digested in a 10-20 μL reaction and incubated at 37 °C for 1-2 hours. For chromosomal 
DNA, 2-5 μg was digested in a 50 μL reaction and incubated at 37 °C for 8-16 hours. 
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2.3 Agarose gel electrophoresis. 
For the separation of high molecular weight DNA fragments, 0.8 % - 1 % agarose gels; 
prepared in 1 × TAE buffer (1 mM EDTA, 40 mM Tris-acetic acid pH 8.5); were used. 
For low molecular weight DNA fragments in the size range of 1 kb or lower, 2 % 
agarose gels were used. All gels contained 0.5 μg/mL ethidium bromide and the DNA 
samples were loaded with a tracking dye (0.025 % bromophenol blue in 30 % glycerol). 
Lambda DNA molecular weight markers (III, IV, and VI respectively; Roche Applied 
Science) were used to assess DNA fragment sizes. The agarose gels were 
electrophoresed at 80 –100 V in a Mini-Sub Cell GT mini gel horizontal submarine unit 
(BIO-RAD) and DNA visualized under UV-light using the Gel Doc 2000 system 
(BIORAD). 
 
2.4 Bacterial Transformations. 
2.4.1 Preparations of chemically competent E coli-DH5α cells. 
Rubidium chloride cells were prepared as follows. Briefly, 1mL of a stationary phase 
overnight culture was inoculated into 100 mL LB and grown to an OD600nm of between 
0.5- 0.8. The cells were chilled on ice for 15 min and harvested (3901 × g for 5 min at 4 
°C). The pellets were re-suspended in 20 mL TfbI solution (30 mM potassium acetate, 
100 mM rubidium chloride, 10 mM calcium chloride, 50 mM manganese chloride, and 
15 % v/v glycerol - pH 5.8), and chilled on ice for 15 min. The cells were re-harvested 
(3901 × g for 5 min at 4 °C), re-suspended in 2 mL TfbII solution (10 mM MOPS [3-N-
morpholino propanesulfonic acid], 75 mM calcium chloride, 10 mM rubidium chloride 
and 15 % v/v glycerol-pH 6.5) and 500 μL aliquots were flash-frozen in ethanol and 
stored at -80 °C until further use. 
 
2.4.2 Transformations into E. coli-DH5α competent cells. 
E. coli-DH5α competent cells stored at -80 °C were thawed on ice and a 100 μL aliquot 
was used per transformation. Up to 1 μg plasmid DNA was incubated with the cells on 
ice for 1 hour, heat-shocked for 90 sec at 42 °C and chilled on ice for 2 min.  One mL of 
2XTY (Tryptone Yeast) was then added to rescue the cells at 37 °C for 1hour. The cells 
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were then spread on LA media containing the appropriate antibiotics, and incubated for 
1 - 2 days at 37 °C. 
 
2.4.3 Preparation of competent M. smegmatis cells. 
One millilitre of a stationary phase M. smegmatis culture was inoculated in 100 mL LB 
containing 0.05 % Tween80 and grown to an OD600nm of 0.5 - 0.8. The cells were 
harvested by centrifugation (2360 × g for 10 minutes at 4°C) and the pellet washed 
thrice by gentle re-suspension in 30 mL ice-cold 10 % glycerol and harvested by 
centrifugation at 2360 × g for 10 min at 4°C. The pellet was suspended in 1 mL ice-cold 
10 % glycerol and these competent cells were used immediately. 
 
2.4.4 Electroporation into competent M. smegmatis cells. 
A maximum of 5 μg plasmid DNA was added to 400 μL of M. smegmatis competent 
cells and incubated on ice for 15 min. This mixture was transferred to a 0.2 cm 
electroporation cuvette and pulsed using the Biorad Gene PulserX cellsTM electroporator 
at the following settings: 2.5 kV, 25 μF and 1000 Ω. The cells were rescued immediately 
with 800 μL of 2XTY for at least 3-16 hours at 37 °C. The cells were subsequently 
spread on Middlebrook 7H10 media containing the appropriate supplements and 
antibiotics, and incubated for 3 - 7 days at 37 °C.  
 
2.5 Southern Blot analysis (Southern, 1975). 
Approximately 2-3 μg of genomic DNA was digested overnight at 37 °C with the 
appropriate restriction enzyme and the DNA fragments were separated on a 0.8% 
agarose gel at 80 V for 2 hours. The DNA was initially depurinated by treating the 
agarose gel with a 0.25 M HCl solution for 15 min, then denatured by soaking in a 0.5 M 
NaOH/ 1.5 M NaCl solution for 15 min. The gel was subsequently equilibrated in 1 
×TBE buffer (Tris-Borate-EDTA pH 8.0, Sigma). The agarose gel was overlaid with a 
HybondTM – N nitrocellulose membrane, sandwiched between two pre-soaked Whatman 
filter papers, and two pre-soaked sponges. After ensuring that no air bubbles were 
present, this “sandwich” was carefully placed in a TE 22 Mini Transphor cassette which 
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was transferred to a TE 22 Mini Transphor unit (OmniPAGEElectro-blotting Unit 
(Cleaver Scientific Ltd CS-300V) containing 1 × TBE buffer. The DNA was transferred to 
the nitrocellulose membrane (0.5 A for 2hours at 4°C) and cross-linked by irradiation at 
1200 mJ/cm2 in a UV Stratalinker (1800 Stratagene). Thereafter, the DNA was 
transferred onto a nitrocellulose membrane, the membrane was pre-hybridised in pre-
hybridisation solution (0.5 % SDS, 6 ×SSC, 5 × Denhardts and 50 % deionised 
formamide) at 42 °C with 10 μg/mL heat denatured salmon sperm DNA (Roche Applied 
Science) in a Techne HybridizerHB-1 roller bottle. 
 
The probe was hybridised to the membrane with 12 mL DIG (Dioxygen) EasyHyb 
solution for 1 hour at 56 °C in Hybaid HB-OV-BM roller bottles incubated in a 
hybridization oven (Hybaid Micro-4). Prior to hybridization, the probe was heat-
denatured (95 °C for 10 min) and added to the pre-hybridisation solution and 
hybridization was allowed to occur overnight at 56 °C. The membrane was then washed 
twice with Solution I (2× SSC, 0.1 % SDS) at room temperature for 5 min and then once 
with Solution II (0.5 × SSC, 0.1 % SDS) at 65 °C for 30 min. Following these washes, 
detection of the DIG-labelled hybrids was carried out by dephosphorylation of the 
CSPD® substrate upon addition of a specific DIG alkaline phosphatase-conjugated 
antibody, which resulted in chemiluminescence at 477 nm. This enabled visualization of 
DNA on X-ray film after 30 min–4 hours of incubation at room temperature. 
 
2.6 Knockout vectors used in this study 
Plasmid constructs containing inactivated alleles of the nth and nei genes were 
previously generated by PCR and cloning as part of a Masters study (Goosens, 2009, 
Moolla et al., 2014). The strategy for creating the knockout vector is shown in Figure 
2.1. Briefly, approximately 1500 bp upstream (green bar) and downstream (orange bar) 
(shown in Figure 2.1 below) of the genes of interest were amplified by PCR using a high 
fidelity polymerase and primers that had appropriate restriction sites incorporated within 
the sequence to facilitate cloning. The amplified upstream and downstream fragments 
were cloned into pGEM3Zf (+) and sequenced to ensure mutations were not introduced 
during the PCR cycling (II, in Figure 2.1). Subsequently, the upstream and downstream 
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fragments were excised from pGEM3Zf (+) and cloned by three way cloning into the 
suicide vector, p2NIL which carries a kanR marker (III – in Figure 2.1). The PacI 
cassette from pGOAL19 containing marker genes sacB and lacZ and hygR was inserted 
into the PacI site of p2NIL to generate 2NILΔnth::pGOAL19 (IV – in Figure 2.1).  
 
 
 
 
  
 
 
 
Figure 2.1: Schematic representation of the construction of knockout 
constructs using three way cloning. Initially PCR products of upstream region (US 
- green) and downstream (DS - orange) region are cloned separately into the pGEM 
vector, subsequently the US and DS regions and a Pac cassette are ligated together 
into p2NIL vector to make the final construct. The blue bar represents ampicillin 
resistance, purple bar represents kanamycin resistance and red bar represents 
hygromycin resistance. The black arrows represent regions amplified by the forward 
and reverse primers. 
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2.7 Inactivation of the Nth DNA glycosylase to generate double deletion 
mutants. 
Two-step allelic exchange by homologous recombination, described by (Gordhan and 
Parish, 2001), was used to generate M. smegmatis knock-out mutants. A schematic 
representation of this technique is depicted in Figure 2.2 below. The method involves 
the construction of a knockout vector, shown in Figure 2.1. Once introduced into the M. 
smegmatis cell, a single cross-over (SCO) event between the chromosome and one of 
the regions of homology on the knockout vector results in the integration of the knockout 
vector into the chromosome. The knockout vector carries the selectable marker genes 
aph, hyg and lacZ which allow for the selection of SCO homologous recombinants, 
identified as blue colonies growing in the presence of X-gal, kan and hyg. Also carried 
on the knockout vector is the sacB gene, which encodes levansucrase. When grown in 
the presence of sucrose, cells carrying the sacB gene produce levansucrase which 
converts sucrose to fructose polymers. Accumulation of these polymers in the cell 
envelope becomes toxic, resulting in cell death. The sacB gene therefore serves as a 
counter-selectable marker, facilitating a second cross-over event which would result in 
the expulsion of the vector backbone to either generate a knock-out mutant or 
reconstitute the wild type allele if the second cross over occurs on the same side. Cells 
in which the second cross-over event occurs will be white in the presence of X-gal and 
will be sucrose resistant. 
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2.7.1 Generation of SCO and DCO transformants. 
The p2NILΔnth::pGOAL19 suicide plasmid was electroporated into mid-logarithmic 
phase cultures of the ΔneiI and ΔneiII deletion mutant strains respectively and selected 
on 7H10 plates containing kan and X-gal to identify the SCO’s. Blue colonies on the 
plate were considered to be potential SCO’s that result due to the hydrolysis of X-gal by 
Figure 2.2: Schematic representation of knock out mutant generation. 
A non-replicating plasmid carrying a mutated version of the gene is introduced into 
M. smegmatis 1. Homologous recombination leads to single cross-overs (SCO) 2, 
where a single recombination event has occurred or double cross-overs (DCO) 3 
where two recombination events have occurred. Single crossovers carry both the 
wild-type (purple bar) and mutated alleles (green bar) and marker genes (blue bar) 
found on the plasmid, whereas double cross-overs will carry only the deleted copy 
of the gene (green bar) and no marker genes. 
2. 
1. 
3. 
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β-galactosidase, encoded by the lacZ gene in p2NIL, which is integrated into the 
genome. The genotype of the SCO’s was confirmed by PCR and Southern blot 
analysis. For the PCR, chromosomal DNA was extracted from potential SCO’s using the 
colony boil method and the DNA amplified using primers listed in Appendix B. Table 6.1 
that distinguished the mutant and the wild type alleles. 
 
To generate DCO mutants, one of the PCR confirmed SCO’s was selected and grown 
overnight in 10 mL 7H9 with kanamycin. The overnight culture was inoculated into 20 
mL of fresh 7H9 without antibiotics and grown at 37 °C overnight to allow for the second 
crossover to take place. The cells were serially diluted (10-fold) and 100 μL of each 
dilution (100-108) was spread on 7H10 media supplemented with 2 % sucrose and X-
gal. Plates were incubated at 37 °C and scored for white sucrose resistant colonies after 
3 days, which were potential DCO mutants. Potential DCO’s were further confirmed for 
kanamycin sensitivity by spotting on 7H10 media with and without the antibiotic. The 
colonies with confirmed kanamycin sensitivity were screened initially by PCR to 
distinguish between wild type and mutant alleles. The PCR confirmed mutants together 
with the SCO and parental stain were then analysed by Southern blot to ensure that the 
genes upstream and downstream of the mutated allele were genotypically correct.  
 
2.8 Complementation of mutant strains. 
To confirm whether the observed phenotypes were due to the inactivation of the genes 
of interest, complementation strains were generated. The complemented  constructs 
were generated by a previous Masters student (Moolla et al., 2014). Briefly the full 
length functional nth gene with an additional 350 bp upstream sequence carrying the 
promoter region was amplified and cloned into the integrating vector pTWEETY to 
generate pTWEETY::nth. In this study the integrity of the construct was re-evaluated by 
restriction analysis. The appropriate complementation vector was electroporated into 
the respective mutant strain and the resulting clones were screened by PCR. Using this 
strategy, two complemented strains, (∆neiI ∆nth::nth and ∆neiII ∆nth::nth) were 
generated. 
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2.9 Phenotypic analysis of mutants. 
2.9.1 Growth Kinetics under normal culture conditions. 
To determine the growth kinetics of the various mutant strains, 1 mL freezer stocks 
were grown overnight at 37 °C in 5 mL 7H9 medium with shaking at 100 rpm. The 
overnight late log phase culture was diluted into 50 mL of fresh media to a starting 
OD600nm of 0.02 and growth of the cultures was monitored by OD600nm measurements 
every 3 hours for a period of 36 hours. Growth was represented graphically as optical 
density over time.  
 
2.9.2 Mutation frequency. 
For mutation frequency analysis, bacterial strains were grown overnight in 20 mL 7H9 at 
37 °C to an OD600nm of 0.3-0.5. The cultures were washed twice by centrifuging at 16168 
x g for 10 min and re-suspended in 20 mL of 7H9 broth. Aliquots (100 µL) of 10 fold 
serial dilutions (104-107) were spread onto 7H10 media for colony forming unit (CFU) 
counts. A 1 mL aliquot of the cells was spread onto 7H10 supplemented with 200 µg/mL 
rifampicin (rif) and incubated at 37 °C. The plates were scored after 7 days for rifampicin 
resistant (rifR) colonies. The mutation frequency was calculated as total number of rifR 
colonies over the total number of colony forming units (CFU/mL) per culture.  
 
2.9.3 Sensitivity to hydrogen peroxide. 
To assess the sensitivity of the various mutants under oxidative stress conditions, about 
20 mL of the various mutant and complemented strains were grown to an OD600nm of 
0.3-0.4. A 5 mL aliquot of each culture was dispensed into a flask and treated with 2 
mM of hydrogen peroxide. The treated cultures were incubated at 37 °C for three hours 
in the dark. After the three hours incubation, 100 µl aliquots of 10 fold serial dilutions 
(104-107) were spread onto 7H10 media for CFU counts.  
 
2.9.4 Spontaneous mutation rates. 
A mutation rate measures the probability of a cell acquiring a mutation during its lifetime 
and takes into account the possibility of mutations arising early or late during the growth 
phase. The Luria-Delbrück fluctuation analysis was used to measure spontaneous 
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mutation rates for the various mutants (Rosche and Foster, 2000). The numbers of 
mutational events that occur are accurately calculated by using parallel cultures, 
thereby minimizing variability. The mutation rate was calculated using a previously 
created excel spreadsheet (E. Machowski, CBTBR). Briefly, mutation rate is taken as 
the number of observed mutations per culture (m) within the total population (Nt). There 
are two methods suggested for estimating the overall mutation rate of the population: 
the p0 method, which is based on the proportion of cultures in which there are no 
mutants observed, and the method of the mean (Lea-Coulson method), which relies on 
the determination of the mean number of mutants. Both methods assume a Poisson 
distribution, shown in Figure 2.3, with a mean and variance equal to the product of the 
probability of a mutation and the number of bacteria. This method uses an estimate of 
the number of mutational events (not the number of mutants), m (Purple arrow), to 
determine the mutation rate that have a Luria–Delbrück distribution. The parameter m 
will be influenced by the amount of growth and the mutation rate (µ). The estimated 
value of m can be divided by the total number of cells to give the mutation rate. The 
Lea-Coulson Maximum Likelihood method (MSS-LC) was used when a high number of 
rifR mutants (m-value) were obtained on selective plates. Mutation rate was calculated 
using the following formula: 
  
 
 
 
Figure 2.3: Example of the MSS-LC distribution graph/curve used to 
estimate the RifR mutants per culture (m-value).  The purple arrow shows the 
peak on the graph at which the m-value is estimated.  
m - Value X In2 
Nt - value 
μ = 
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Freezer stocks of the parental, mutant and complemented strains were streaked on 
7H10 and incubated at 37 °C until single colonies emerged. Single colonies from the 
respective strains were grown in 7H9 media to late log phase (108cells/mL). A dilution 
series from 108-100 of the culture was performed and spread on 7H10 media to 
measure the initial inoculum (N0). Also, 1 mL of the culture was spread onto 7H10 
plates containing 200 µg/mL of rif to ensure no pre-existing mutants were present. The 
cell density was diluted from 108cells/mL to 102 cells/mL and 2 mL aliquots of the 102 
dilution were dispensed into 30 culture tubes and incubated at 37 °C with constant 
shaking (100 rpm) for 7 days until the cultures were in late log phase. The total 
population size (CFU/mL) was determined by randomly selecting 5 culture tubes out of 
the 30 and spreading a serial dilution of the cells from 108-100 on 7H10 plates (Nt).The 
culture from the remaining 25 tubes was plated individually on 7H10 rif (200 µg/mL) to 
score for spontaneous rifR mutants (m-value) (refer to Figure 2.4). The 7H10 plates were 
incubated at 37 °C for 3 days for total population size count and 7 days for scoring rifR 
colonies.  
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Figure 2.4: Schematic outline of the fluctuation assay experiment. 
The fluctuation analysis is based on the probability of an organism developing a mutation 
per cell division in the lifetime of the bacterial cell. The fluctuation assay was set up with a 
number of parallel cultures (30 tubes), each containing the same number of cells, which 
were allowed to grow and 5 out of the 30 tubes were selected to determine the total 
number of cells. The remaining culture was plated on 7H10 media containing rifampicin. 
The mutation rates were calculated for each strain using the computer software program 
developed in the laboratory. 
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3. Results 
3.1 Bioinformatics analysis 
The bioinformatics analysis was aimed at highlighting the differences and the similarities 
between the two Nei homologues, and then comparing them in M. smegmatis and M. 
tuberculosis.  
 
The general structure of the Nei DNA glycosylases consists of three distinct domains 
including the zinc finger and the helix-2-turn-helix (H2TH) domains, which are involved 
in DNA binding, and a Fapy DNA glycosylase domain that has hydrolytic activity and 
hydrolyses the N-glycosidic bond in the DNA. The Pfam database 
(http://pfam.xfam.org/) was used to confirm the structural features of the Nei protein in 
M. smegmatis: As illustrated in Figure 3.1 A, NeiI does show the presence of the H2TH 
and the zinc finger motifs. However, interestingly the NeiII homologue has an additional 
Fapy DNA glycosylase, see Figure 3.1 B.  
Three dimensional protein structures of the Nei homologues were also modelled to 
further examine the positioning of the motifs within the two Nei homologues. Nei 
consists of two domains and possesses several defined structural motifs whose 
functional importance is evident from the structure. In particular, the enzyme flips the 
damaged nucleotide from DNA to gain access to C1’, a target for nucleophilic attack by 
the N-terminal proline moiety. This flipping, referred to as “base flipping”, is 
accompanied by the insertion of three amino acid residues (Gln-69, Leu-70 and Tyr-71, 
referred to here as the QLY loop or the intercalation loop) into the void left in the helix 
after base extrusion. The amino acids forming this short loop also participate in un-
stacking of the base, opposite the lesion, introducing a sharp kink into the DNA, and 
forming hydrogen bonds with the base opposite the lesion, thereby contributing to the 
observed opposite-base specificity. NeiI uses the GLY-loop and NeiII uses a KME-loop 
for intercalation (Figure 3.1 C and D). The overall crystal structure of M. smegmatis NeiI 
and NeiII comprises two domains connected by a hinge polypeptide (Fig. 3.1 C and D) 
and resembles that of E. coli Nei (Zharkov et al., 2002). The N-terminal domain contains 
strands, forming a sandwich with two helices parallel to its edges shown in red in 
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Figure. 3.1 C and D. The C-terminal domain includes four -helices, two of which (shown 
in yellow, orange, light green and blue in Fig. 3.1 C and D) form the helix-two turn-helix 
(H2TH) motif, and two strands that form a hairpin zinc finger. There is also a Cys4 type 
zinc finger (indicated on the yellow strand with sticks) (Arg-171) which is involved in 
tight network hydrogen bonds surrounding the lesion that hold DNA in a highly distorted 
conformation. Amino acids Arg-171 and Gln-252 are involved in the positioning of the 
zinc finger (Fromme and Verdine, 2002).  
 
 
A
.  
B.  
NeiI 
NeiII 
NeiI 
NeiII 
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The protein database of Clusters of Orthologous Groups 
(http://www.ebi.ac.uk/Tools/msa/clustalo/) was used to identify the Nei glycosylase of 
several microorganisms and the amino acid composition of the Nei protein in these 
organisms was analysed by Clustal Omega alignments (Fig. 3.2). Sequences of the Nei 
homologues from the following microorganisms were assessed: Escherichia coli (E. 
coli), Salmonella typhimurium (S), Xanthomonas campestris (X), Streptomyces (Strep), 
Corynobacterium (Cory), M. tuberculosis (Tb-neiII and Tb-neiI) and compared to the M. 
smegmatis counterparts (Smeg-neiI and Smeg-neiII) The Nei glycosylases motifs in the 
various organisms showed significant similarity except for the difference in the 
intercalating loop between the M. smegmatis and M. tuberculosis NeiII DNA 
glycosylases.  
 
C.  D.  
Figure 3.1: Structural characteristics of the M. smegmatis Nei protein. A 
and B pfam results of the M. smegmatis NeiI and NeiII homologues 
respectively depicting the different motifs. The pink bar indicates the H2TH, 
red bar shows the zinc finger and the turquoise bar depicts the Fapy DNA 
glycosylase motif. C and D shows three-dimensional structures of the M. 
smegmatis Nei showing H2TH (orange cluster), Fapy DNA glycosyse (blue 
cluster) and the zinc finger (red cluster) motifs. The white arrows indicate the 
important amino acids residues for DNA binding and excision. 
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X.             MHARASGCRVHRDHGRITQRFDTGRMPEGPSLVILREDTQAFVGRKIVRVSGN----SKQ 
E.coli         -------------------------MPEGPEIRRAADNLEAAIKGKPLTDVWFAFPQLKP 
S.             -------------------------MPEGPEIRRAADNLEAAIKGKPLTDVWFAFAQLKP 
Mtb-neiI       -------------------------VPEGHTLHRLARLHQRRFAGAPVSVSSP-QGRFAD 
Smeg-neiI      -------------------------MPEGHTLHRLARLHQRRFGRTAVVVSSP-QGRFAD 
Cory           -------------------------MPEGDSVFQLSRKLQ-FMRGREVLETSLRVPSV-- 
Strep          -------------------------MPEGDTVWQAARRLHDALAGRVLTRSDFRVPRY-- 
Mtb-neiII      -------------------------MPEGDTVWHTAATLRRHLAGRTLTRCDIRVPRF-- 
Smeg-neiII     -------------------------MPEGDTVFHTAAALRAALEGKTLTRCDVRVPRY-- 
                                        :***  :       .  .    :             
 
X.             DIARLDQQKVLALRSWGKHFLIEF-AHFSVRIHFLLFGSYRINEDKP-------NAVPRL 
E.coli         YQSQLIGQHVTHVETRGKALLTHFSNDLTLYSHNQLYGVWRVVDT-GEE--PQTTRVLRV 
S.             YESQLTGQLVTRIETRGKALLTHFSNGLTLYSHNQLYGVWRVIDT-GEI--PQTTRILRV 
Mtb-neiI       SASALNGRVLRRASAWGKHLFHHYVGGPVVHVHLGLYGTFTEWARPTDGWLPEPAGQVRM 
Smeg-neiI      GAAAVSGQIFKRATAWGKHLFHHYDGGRVVHIHLGLYGAFTEWPVPAELALPLPVGQVRM 
Cory           ALHDFTGQTVHRVWPYGKNLFMQF-GEEILHTHLKMEGTWAVHRK-GDRWRK-PAHTARV 
Strep          ATVDLTGRTVLDVTPRGKHLLTRVEGGLTVHSHLRMDGSWKVFAP-GQRWSGGPAHQIRV 
Mtb-neiII      AAVDLTGEVVDEVISRGKHLFIRT-GTASIHSHLQMDGSWRVGNR-PVR----VDHRARI 
Smeg-neiII     ATVDLSGAVVDEVLSRGKHLFIRA-GSASIHSHLKMEGAWRIGHT-KVA-----PHRIRI 
                   .    .      ** :: .      :  *  : * :                  *: 
X.             GLEF---SNGQRLNFY-ACSVQFIE----RPLDEVYDWTADVMNPLWDPAQARRKLRAA- 
E.coli         KLQT----ADKTILLYSASDIEMLTPEQLTTHPFLQRVGPDVLDPNLTPEVVKERLLSPR 
S.             RLQT----ADKTILLYSASDIEMLTAEQLTTHPFLQRVGPDVLDARLTPEEVKARLLSPR 
Mtb-nei1       RMVGAEFGTDLR----GPTVCESIDDG--EVADVVARLGPDPLRSDANPSSAWSRI-TK- 
Smeg-nei1      RIIGAQYGTDLR----GPTVCELITEP--EIVDVIAKLGPDPLRPDADASLAWKRI-TK- 
Cory           VLVLS---ENIEVVGHSLGFVRVFPTN--RYLEEISHLGPDVLAEHFDIDTARNNIASN- 
Strep          ILGT----ADRTAVGYRLPVLDILRTA--EEQRAVGHLGPDLLGPDWDPERALDNLRAD- 
Mtb-neiII      ILEANQQEQAIRVVGVDLGLLEVIDRH--NDGAVVAHLGPDLLADDWDPQRAAANLIVA- 
Smeg-neiII     VLET----ADTRAIGIDLGILEVLDRG--TDMDAVAYLGPDLLGPDWEPRVAADNLAAD- 
                :                     :          :     * :        .  .:     
 
X.             -PALLAADALLDQTIFAGVGNIIKNEVLHRIRVHPESTVGALPARKLGELVTQARDYSFD 
E.coli         FRNRQFAGLLLDQAFLAGLGNYLRVEILWQVGLTGNHKAKDLNAAQLDALAHALLEIPRF 
S.             FRNRQFSGLLLDQSFLAGLGNYLRVEILWQVGLTGQHKAKDLNEAQLNALSHALLDIPRL 
Mtb-neiI       -SRRPIGALLMDQTVIAGVGNVYRNELLFRHRIDPQRPGRGIGEPEFDAAWNDLVSLMKV 
Smeg-neiI      -SRRPIGALLMDQTVMAGVGNVYRSELLFRHGIDPYLPGTQLDAAEFDAMWTDLVALMKV 
Cory           -PSRTIGEALLDQSNLAGVGNEYRAEICFLMGIHPATPVSAVDVEKA---LKITRRLMWE 
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Strep          -PPRALGEALLDQRNLAGIGNVYKSELCFLLGVTPWLPVGELPADRAARLPTLAKKLLEA 
Mtb-neiII      -PDRPIAEALLDQRVLAGIGNVYCNELCFVSGVLPTAPVSAVADPR--RLVTRARDMLWV 
Smeg-neiII     -PDRPLAQALLDQRVMAGVGNVYCNELCFVFGRLPTAPVGTLKDPL--RVVQRARDMLWL 
                     .  *:**  :**:**    *:              :                   
 
X.             FYTWKKAFVLKKHYQV-----------------HTKTSCPRDGAPLQYRKH-LGKAGRRA 
E.coli         SYATRGQVDEN---------KHHGALFRFKVFHRDGEPCERCGSIIEK----TTLSSRPF 
S.             SYTTRGQADEN---------KHHGALFRFKLFHRDGEACERCGGIIEK----TTLSSRPF 
Mtb-neiI       GLR-RGKIIVVRPEHDHGLPSYLPDRPRTYVYRRAGEPCRVCGGVIRT----ALLEGRNV 
Smeg-neiI      GVR-RGKIVVVRPEHDHGAPSYRTGRPRTYVYRRAGEPCRICGTPVRT----AELEGRNL 
Cory           ----------NRNSPIRVTTGIRRAGESTYVFGRNNKPCRRCRSTIVK----AELGERII 
Strep          ----------NRDRPVRRTTG--LRGQDLFVYGRAPRPCLRCGTSVRVADQGDGSRERPT 
Mtb-neiII      ----------NRFRWNRCTTGDTRAGRRLWVYGRAGQGCRRCGTLIAY----DTTDERVR 
Smeg-neiII     ----------NRSRWNRTTTGDTRNGRQLWVYGRAGEPCRRCGTLIQT----DRGGERVT 
                                                :    *      :           *   
 
 
 
 
 
 
 
 
 
Analysis of the M. tuberculosis Nei homologues as described for M. smegmatis also 
showed conservation of the intercalating loop in both the homologues, Figure 3.3. 
Eukaryotic homologues of Nei proteins have been identified and exhibit some 
structural variations. The structure of the human NEIL1 is similar to that of E. coli 
Nei, it lacks the cysteine residues coordinating Zn2+ but shows an unusual “zinc-less 
finger” motif that functions as a zinc finger (Brieba, 2004). According to sequence 
alignments and pfam analysis this “zinc-less finger” motif was also observed in the 
M. tuberculosis NeiII homologue (see Figure 3.3 A and B). The functional 
consequences of this difference remain unknown. 
 
Fig. 3.2: Alignments of the amino acid sequences of the Nei protein from 
various microorganisms. Sequences were downloaded from CMR for 
Escherichia coli, Salmonella typhimurium (S.), Xanthomonas campestris (X), 
Streptomyces (Strep), Corynobacterium (Cory), Mycobacterium tuberculosis 
(Mtb-neiII and Mtb-nei1) and Mycobacterium smegmatis (Smeg-neiI and Smeg-
neiII). The H2TH motif is outlined by the blue line and elements of the Fapy 
DNA glycosylase motif is shown by the green line. The zinc-finger domain is 
showed by red line. Important motifs are shown in coloured highlights. 
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A
  
B 
C D 
Figure 3.3: Structural characteristics of the M. tuberculosis Nei protein. A & B 
pfam results of the M. tuberculosis NeiI and NeiII homologues respectively depicting 
the different motifs. The green bar indicates the H2TH, pink bar shows the zinc finger 
and the red bar depicts the Fapy DNA glycosylase motif. C and D shows three-
dimensional structures of the M. tuberculosis Nei showing H2TH (orange cluster), 
Fapy DNA glycosyse (blue cluster) and zinc finger (red cluster) motifs. The white 
arrows indicate the important amino acids residues for DNA binding and excision.   
 
 
271 aa 
268 aa 
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3.2 Confirmation of pre-existing mutants. 
Single mutants lacking either neiI or neiII (∆neiI and ∆neiII) that were previously 
constructed in our laboratory (Goosens, 2009, Moolla et al., 2014) were used to 
generate double deletion mutants lacking the nth DNA glycosylase in each of these 
backgrounds to generate ∆neiI ∆nth and ∆neiII ∆nth. Prior to using these single mutants 
as recipient strains, PCR confirmation was carried out to ensure that the mutant strains 
were correct and did indeed lack the respective Nei homologue (see Figure 3.4 and 
3.5). The expected band sizes were observed for all the primer sets used (listed in 
Table 6.1, Appendix D) with genomic DNA from the respective mutants and the parental 
strains. 
 
3.2.1 Confirmation of the ∆neiI mutant strain. 
 
 
 
 
 
Figure 3.4: Confirmation of ∆neiI single mutant. A. Gel electrophoresis image 
showing the ∆neiI mutants, VI depicts Molecular Weight Marker VI, NTC depicts no 
template control, 1 represents amplification of the DNA with neiI specific primers, 2 
represent amplification of the DNA with neiII specific primers and 3 represent 
amplification of the DNA with nth specific primers. B. Table listing the expected band 
sizes from each primer set with DNA from the wild type and mutant strains. 
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3.2.2 Confirmation of the ∆neiII mutant strain. 
 
 
 
 
 
 
 
All previously generated strains amplified the expected band sizes (Figure 3.4 and 3.5) 
confirming that the strains were correct. The strains were taken further for gene 
knockout using homologous recombination to generate double mutant strains.   
 
3.3 Confirmation of previously constructed knockout vector. 
In order to ensure that the suicide vector construct carrying the deleted allele for nth 
generated in a previous study (Moolla et al., 2014) was still intact, DNA from the E. coli 
strains carrying the p2NILΔnth::pGOAL19 knockout vector, was isolated and profiled 
with various restriction enzymes. The restriction profile of the knockout construct yielded 
Figure 3.5: Confirmation of ∆neiII single mutant. A. Gel electrophoresis image 
showing the ∆neiII mutants, VI depicts Molecular Weight Marker VI, NTC depicts no 
template control, 1 represents amplification of the DNA with neiI specific primers, 2 
represent amplification of the DNA with neiII specific primers and 3 represent 
amplification of the DNA with nth specific primers. B. Table listing the expected band 
sizes from each primer set with DNA from the wild type and mutant strains. 
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the expected band sizes thus confirming that the knockout vector was correct (see 
Figure 3.6). The extra band circled in red in Fig 3.6 C is the result of partial digestion of 
plasmid DNA. This could be due to contaminants or inhibitors that affect the activity of 
the restriction enzyme.  
 
 
  
Enzymes used Size of fragments (bp) 
HindIII 9451, 4655, 836 
KpnI 6803, 5797, 1580, 1132, 30 
MLuI 10027, 3371, 815, 490 
NruI 4960, 4356, 2608, 1466, 869, 270 
PvuII 8606, 2537, 2357, 819, 114, 102 
SphI 14784 
 
 
 
 
 
Figure 3.6: Confirmation of the p2NIL∆nth:: pGOAL19 knockout construct 
using restriction enzyme digestion. A. Restriction map of the 
p2NIL∆nth::pGOAL19 vector. B. Expected sizes of fragments for a selection of 
restriction enzymes used for profiling. C. Restriction analysis of 
p2NIL∆nth::pGOAL19 in which the restriction digests all corresponded to the 
expected sizes. 
Pvu
II 
Sph
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3.4 Generation of double deletion mutants  deficient in the Nth and Nei DNA 
glycosylases 
3.4.1 Isolation of single cross over single cross over (SCO) and double cross 
over (DCO). 
The knockout vector p2NIL∆nth::pGOAL19 was electroporated into the Nei deficient 
mutant strains (∆neiI and ∆neiII) that were previously generated using homologous 
recombination in the laboratory (Goosens, 2009). Blue transformants/colonies 
represented single cross over (SCO) mutants containing the functional copy and a 
deleted allele of nth together with the selectable and counter-selectable vector marker 
genes (Figure 2.2). The genotype of the SCO was confirmed by PCR before the SCO 
mutants were subjected to undergo a second cross over event in the presence of 
sucrose to generate a double cross over (DCO) mutant. This two-step selection process 
ensures that only colonies that have lost the sacB cassette will be able to survive in the 
presence of sucrose as the expression of the sacB gene produces levansucrase which 
is toxic to the cell. Hence, colonies that retain the sacB cassette will not be viable in the 
presence of sucrose. Loss of the sacB gene results in the simultaneous loss of the lacZ 
gene therefore, the resulting colonies which are possible DCOs (∆nei ∆nth double 
deletion mutants) will be white and sucrose resistant. The white colonies could also be 
wild type revertants if the second crossover occurs on the same side as the SCO 
(depicted in Figure 2.2). This process yielded several white colonies which were 
assessed further by PCR. 
 
3.4.2 Confirmation of double deletion mutants by PCR. 
Primer set NthF1 and NthR1 listed in Table 6.1 (Appendix D) were used to discriminate 
between clones containing an intact copy of the nth allele and mutants that had a 
disrupted copy of the nth allele. Chromosomal DNA from 10 possible DCO isolates from 
the two mutant strains (∆neiI ∆nth and ∆neiII ∆nth) was amplified and the expected size 
for the intact nth allele (780 bp) was obtained, (see Figure 3.7 A and B) in the parental 
strain (WT) a smaller 270 bp fragment was observed when the functional copy was 
replaced with a disrupted copy of the nth gene in the Nei deficient mutant strains (∆neiI 
and ∆neiII). 
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5’ 
5’ 
5’ 
5’ 
3’ 
3’ 
3’ 
3’ 
Figure 3.7: PCR screen for identification of DCOs using nth primers. A. Schematic 
diagram showing screening primers (green) with expected band sizes. B. and C. 
Agarose gel showing the PCR screen for deletion of nth in the ΔneiI and ΔneiII deletion 
mutants respectively. [Lane 1] Marker VI, [Lane 2] mc2155, [Lane 3] SCO strain, [Lane 
4] p2NILΔnth:pGOAL19, [Lane 5 to 15] Possible DCO ΔneiI Δnth (B) or ΔneiII Δnth 
clones (C). Expected sizes, for wild type (mc2 155) is 780 bp and for the Δnth is 270 bp. 
 
A. 
B. 
C. 
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From the 10 colonies that were picked for the ΔneiI background, PCR confirmed that 5 
clones were the Δnth ΔneiI mutants (Fig. 3.7 B). SCOs showed the expected two 
amplicons with a preference for the deleted allele as it is smaller. From the 10 colonies 
that were picked for the ΔneiII background, PCR confirmed that 7 clones were the Δnth 
ΔneiII mutants (Fig. 3.7 C). Five PCR verified DCOs from each strain were analysed 
further by Southern blot analyses to ensure that the mutants were genotypically intact. 
3.4.3 Southern blot confirmation of double mutants. 
Southern blot analysis was used to ascertain the integrity of the upstream (US) and 
downstream (DS) sequences of the deletion region around the nth gene. Genomic DNA 
from the DCOs that were confirmed by PCR was digested with BamHI and the agarose 
gel-separated DNA was transferred onto a nitrocellulose membrane (outlined in section 
2.7) and probed with a chemiluminescently labelled US probe to identify the respective 
predicted sizes. The fragment sizes identified by the US probe were in accordance with 
the expected fragments as predicted by the sequence map (Figure 3.8 A). The WT 
yielded a 1681 bp fragment and all the DCOs (nth mutants) produced a bigger fragment 
of 2612 bp, thus confirming the replacement of the intact nth allele with a non-functional 
allele (Figure 3.8 B and C). For the SCOs, the expected fragment sizes were obtained 
only for the ∆neiI ∆nth (SCO1 9491 bp and 1861 bp) while for the ∆neiII ∆nth SCO the 
bigger expected fragment size (9491 bp) was not observed (Figure 3.6 C) This could be 
due to DNA degradation leading to loss of the larger molecular weight bands. 
 
Since the SCO mutants were correct by PCR analysis (data not shown) and were 
required only for the generation of the DCO in the two step selection process during 
homologous recombination, the Southern blot analysis of the ∆neiII ∆nth SCO was not 
pursued further as the resulting DCOs were all correct with the US and DS regions in 
the correct genotypic context. 
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3.4.4 Genetic complementation of double mutant strains. 
The double mutants generated in this study were complemented with an intact copy of 
the nth gene to confirm that any observed phenotype is due to the deleted nth allele and 
not due to downstream polar effects that may have arisen during mutant construction. 
Complementation of ΔneiI Δnth and ΔneiII Δnth double deletion mutants with the nth 
gene was accomplished by utilizing a previously constructed integrating vector 
containing the intact gene (Moolla et al., 2014). The integrating vector, pTWEETY::nth 
(Table 1.2) has a functional copy of the nth gene with approximately 350 bp additional 
upstream sequence that contains the promoter sequence. To reconfirm genetic integrity 
Figure 3.8: Southern blot upstream analysis of Δnth mutants. A. Southern blot 
strategy/Map to distinguish the wild type, the SCO and DCO. The chromosomal DNA of 
the parental, SCO and DCO was digested with BamHI (probed with the upstream 
fragment indicated by the blue line – US probe) for confirmation of the upstream region. 
B. Radiograph showing the Southern blot analysis of the ∆neiI ∆nth mutants and C. 
Radiograph showing the Southern blot analysis of the ∆neiII ∆nth mutants.  
 
B. 
C. 
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of the integrating vector, restriction enzyme mapping was carried out and the expected 
fragment sizes were observed, thus confirming the integrity of the complementation 
vector (Figure 3.9). The complementation vector, pTWEETY::nth was electroporated 
into the double mutant strains, ΔneiI Δnth and ΔneiII Δnth to genetically revert the strain 
to their ΔneiI and ΔneiII parent single deletion mutant backgrounds. The resulting 
complemented strains were annotated as ΔneiI Δnth::nth and ΔneiII Δnth::nth (Table 
1.1).  
 
Enzymes used Expected Fragment size in bp 
EcoRI 6985 
HindIII 6024, 961 
NruI 4425, 2560 
PvuII 4149, 2836 
 
 
 
 
Figure 3.9: Confirmation of the pTWEETY::nth complementation construct using 
restriction enzyme digestion. A. Restriction map of the pTWEETY::nth integrating 
vector. B. Expected sizes of fragments for a selection of restriction enzymes used for 
profiling. C. Agarose gel showing the restriction analysis of pTWEETY::nth in which the 
restriction digests all corresponded to the expected sizes. 
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The pTWEETY::nth vector was electroporated into the ΔneiI Δnth and ΔneiII Δnth 
strains and the integrants were selected on kanamycin. The integration of the vector in 
the complemented strains was confirmed by PCR using the same conditions as 
described in section 2.3.1 in which the wild type and the mutants nth alleles were 
distinguished based on size difference in the complemented strains (Figure 3.10). The 
re-appearance of the wild type band in the genetically completed strains provided proof 
that the complementation vector integrated into the chromosome.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.10: PCR confirmation of complemented strains. A. and B. represent 
complementation strains shown as the intact copy of the nth gene (780 bp) and the 
disrupted copy of the gene (270 bp). VI -marker VI, WT-wild type, NTC- no template 
control and 1 to 5 represent the complemented strains. 
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3.5 Phenotypic characterization. 
3.5.1 Growth kinetics. 
Growth kinetics of mc2155, the single mutants (∆nth, ∆neiI and ∆neiII), the double 
mutants (∆neiI ∆nth and ∆neiII ∆nth) and the complemented strains (∆neiI ∆nth::nth and 
∆neiII ∆nth::nth) was assessed under normal culture conditions to evaluate the effect of 
the combinatorial loss of nth and nei DNA glycosylases. Log phase cultures of the 
various strains were inoculated in 7H9 media and bacterial growth monitored by 
measuring optical density (OD600nm) at 3 hour intervals over a period of 36 hours. Both 
the double deletion mutant strains showed comparable growth to the parental strain and 
the respective single deletion mutants suggesting that the combinatorial loss of Nth and 
Nei do not affect growth of M. smegmatis under normal culture conditions (Figure 3.11). 
Furthermore, both the complemented strains also displayed the same growth kinetics as 
the respective single gene deletion mutants indicating that integration of the functional 
nth gene at the attB site does not affect the growth kinetics of these strains. 
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Figure 3.11: Growth kinetics of the parental and mutant strains under normal 
culture conditions. Growth of the wild type (WT), Nei and Nth deficient mutants and their 
respective complemented strains was monitored every 3 hours over a 36 hour period. The 
data shows the mean of two independent experiments. 
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3.5.2 Sensitivity to hydrogen peroxide. 
Early log phase cultures (OD600nm of 0.3-0.4) of mc
2155, ∆nth, ∆neiI, ∆neiII, ∆neiI ∆nth, 
∆neiII ∆nth, ∆neiI ∆nth::nth and ∆neiII ∆nth::nth  were exposed to 2.0 mM hydrogen 
peroxide as described in section 2.11.3. The treated cells were monitored for survival by 
assessing cell viable counts (log CFU/mL) over a 3 hour period. This experiment was 
carried out 3 times however, the results were not reproducible for all 3 replicates; the 
different strains gave varying results in each experiment (data not shown). This could be 
due to the effect of the “catalase” enzyme which is found in mycobacterial cells, which is 
secreted into the culture medium. When the enzyme is exposed to oxygen 
it catalyzes the decomposition of hydrogen peroxide to water and oxygen. It is a very 
important enzyme in protecting the cell from oxidative damage by ROS. The varying 
results obtained in this experiment could have been due to the neutralization of 
hydrogen peroxide by the catalase within the mycobacterial cells or within the culture 
medium. To eliminate this possibility, wild type cells from early log phase (OD600nm of 
0.3-0.4) cultures were pelleted and washed twice with 7H9 broth to remove cellular 
biomolecules in the media that might react with the hydrogen peroxide before treating 
with 1 mM and 2 mM concentrations of hydrogen peroxide. The treated cells were 
monitored for survival by assessing cell viable counts (log CFU/mL) hourly over a period 
of 3 hours (Figure 3.12). The washed cells showed notable sensitivity to both 1 and 2 
mM hydrogen peroxide, with a 2 and 3 log reduction after 3 hours, respectively of viable 
cells after 3 hours (Figure 3.12 B). As expected, for the unwashed cells 1 mM of 
hydrogen peroxide was insufficient to reduce the survival of the wild type strain (Figure 
3.2 A) but at 2 mM hydrogen peroxide there was a 5- log reduction in cfu/mL after 3 
hours of exposure. Consolidation of the data for the washed and unwashed cells as 
shown in Figure C, clearly show that washing the cells before treatment with hydrogen 
peroxide does have a greater impact on survival of cells at both the concentrations of 
hydrogen peroxide tested, suggesting that the washing of the cells does remove cellular 
biomolecules that might react with the hydrogen peroxide. 
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Hence, based on this observation, the parental, mutant and complemented strains 
(mc2155, ∆nth, ∆neiI, ∆neiII, ∆neiI ∆nth, ∆neiII ∆nth, ∆neiI ∆nth::nth and ∆neiII ∆nth::nth) 
were grown to early log phase (OD600nm 0.3-0.4),  washed twice with 7H9 broth and 
treated with 2 mM hydrogen peroxide. The data from these experiments are 
represented in Figure 3.11  
C. 
Figure 3.12: Assessment of washed and unwashed wild type M. smegmatis 
strain in the presence of hydrogen peroxide. A. Graph showing the unwashed 
cells when treated with 1 mM (Purple bars) and 2 mM (light blue bars) hydrogen 
peroxide. B. Graph showing the washed cells when treated with 1 mM (blue bars) and 
2 mM (red bars) hydrogen peroxide. C. Graph showing the combined data from 
graphs A and B. The treated strains were monitored hourly for CFU/mL over a period 
of 3 hours; the experiment was repeated 3 times. Error bars represent standard 
deviations between experiments. 
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The two single Nei deletion mutants clearly show differential survival under oxidative 
stress conditions with the NeiI-defective mutant having similar tolerance to the wild type 
strain. Deletion of the neiII allele results in a 1 log reduction in CFU/mL compared to the 
untreated cells. The nth single deletion mutant showed a 3 log reduction in viability in 
the presence of hydrogen peroxide, which was marginally reduced when both the nth 
and neiII genes were inactivated suggesting that in this double mutant, the killing effect 
was due to the loss of the nth DNA glycosylase only. Interestingly deletion of nth 
together with the neiI DNA glycosylase only displayed a one log reduction in viable 
counts suggesting that the remaining intact neiII homologue is able to sufficiently protect 
the DNA under oxidative stress conditions. The observed phenotypes were fully 
Figure 3.13: Assessment of wild type M. smegmatis single, double deletion 
mutants and their respective complemented strain with and without 2 mM 
H2O2. The blue bars shows cells before treatment and red bars indicate the viable 
cells after treatment with 2 mM H2O2, growth was monitored as cfu/mL after 3 hour. 
Error bars represent standard deviations from three experiments.  
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complemented to the levels observed for the single deletion mutants with the intact nth 
gene.  
3.5.3 Assessment of mutation rates by the fluctuation assay. 
The mutation rates were calculated using the Luria-Delbrück fluctuation analysis as 
described in section 2.11.4. The mutation rates were calculated for each strain using the 
computer software program developed in the laboratory by Machowski et al., 2007. The 
Lea-Coulson method was used to create the Luria-Delbrück distribution to estimate the 
m value required for the mutation rate calculation. The mutation rates (μ) are dependent 
on the distribution of mutations (m) in the entire population (Nt) (Rosche and Foster, 
2000). 
 
To investigate the role of the two Nei homologues during mutagenesis the spontaneous 
mutation rates to rifampicin of the various nth and nei deficient mutants were assessed 
and compared to the parental strain as indicated in Table 3.1. The single ∆nth, ∆neiI 
and ∆neiII deletion mutants displayed no increase in mutation rates (Table 3.1 – 
outlined with the blue line) which clearly suggested that the Nei homologs are able to 
compensate for Nth and vice versa. In contrast, deletion of nth together with either neiI 
or neiII homologues results in a 2 and 6-8 fold increase in mutation rate respectively 
(Table 3.1– outlined in the grey box). Both the complemented strains restored the 
functionality of the nth in the double mutants. Loss of the NeiII homologue in 
combination with Nth again showed an increased mutation rate compared to when the 
NeiI homologue was deleted in combination with the Nth DNA glycosylase. Taken 
together these data clearly suggested that NeiII has a greater role in maintaining 
genome integrity under oxidative stress conditions compared to the NeiI homologue. 
These findings indicate a hierarchal role for the various DNA glycosylases in the BER 
pathway for genome maintenance during stressful conditions. 
 
 
 
 
 
Table 3.1: Spontaneous rifampicin resistance mutation rates of the various nth knockout 
double mutant strains compared to M. smegmatis and single mutant parental strains as 
determined by fluctuation analysis. Various nth deleted mutants are outlined in the grey 
box for comparison. The experiment was repeated three times. 
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Mutation rate   Fold change 
Strains  Experiment 1 Experiment 2 Experiment 3 Experiment 1 Experiment 2 Experiment 3 
mc
2 
155 2.06E-09 2.09E-09 1.99E-09 1.0 1.0 1.0 
∆neiI 3.94E-09 3.11E-09 3.75E-09 1.9 1.5 1.9 
∆neiII 2.214E-09 3.47E-09 2.87E-09 1.1 1.7 1.4 
∆nth 2.66E-09 2.41E-09 3.00E-09 1.3 1.2 1.5 
∆neiI ∆nth 5.64E-09 4.52E-09 4.78E-09 2.7 2.2 2.4 
∆neiII ∆nth 1.42E-08 1.74E-08 1.21E-09 6.9 8.3 6.1 
∆neiI ∆nth::nth 7.02E-09 6.33E-09 5.67E-09 3.4 3.0 2.8 
∆neiII ∆nth::nth 8.43E-09 7.87E-09 7.32E-09 4.1 3.8 3.7 
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4. Discussion and Conclusion 
The ability to repair damaged DNA forms a crucial component of the cellular machinery 
in M. tuberculosis as the pathogen is constantly exposed to DNA damaging conditions. 
As such, successful repair of damaged DNA is a key feature of virulence. M. 
tuberculosis is a pathogen that is constantly exposed to a myriad of DNA damaging 
stresses within the host macrophage rendering it important to understand the 
mechanisms involved in repairing DNA damage for the survival of the organism under 
these conditions. 
The importance of DNA repair proteins in survival of M. smegmatis under oxidative 
stress conditions, exposure to UV and during mutagenesis has been previously studied 
(Moolla et al., 2014). These authors assessed the contribution of Nei and Nth DNA 
repair enzymes in M. smegmatis. M. smegmatis mutants lacking neiI, neiII and nth 
individually or in combination did not display aberrant growth in broth culture. The ∆neiII 
∆neiI ∆nth triple mutant showed elevated spontaneous mutation frequencies compared 
to the wild type, the Fpg/Nei deficient mutants and their respective genetically 
complemented strains. These data confirmed that the Nth DNA glycosylase has an 
antimutator role in mycobacteria, similar to its demonstrated role in E. coli and 
Salmonella typhimurium, wherein the Nth DNA glycosylase also exerted a combinatorial 
effect with the Nei homologues in mutation avoidance (Altuvia et al., 1997). In 
comparison the study by Moolla et al also clearly demonstrated a novel interplay 
between the Nth and Nei homologues in DNA damage tolerance (with subsequent 
survival under oxidative stress conditions) and maintenance of spontaneous 
mutagenesis in M. smegmatis (Moolla et al., 2014). Hence, in the present study, we 
aimed to further interrogate the molecular basis of this interplay between the Nth and 
Nei homologues, with the particular aim to understand the individual contribution of the 
Nei homologues in DNA damage tolerance (and subsequent survival) under oxidative 
stress conditions. 
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M. smegmatis NeiI protein lacks a Fapy DNA glycosylase motif.  
Nei DNA glycosylases are members of the Fpg/Nei family of DNA glycosylases involved 
in the identification, excision and repair of oxidatively damage DNA. Genome analysis 
performed in this study identified two putative nei DNA glycosylase-encoding genes in 
M. tuberculosis and M. smegmatis. Bioinformatic analysis confirmed that the M. 
tuberculosis and M. smegmatis genes were DNA glycosylase homologues. 
Furthermore, it was observed that the M. smegmatis and M. tuberculosis neiII-encoded 
proteins had maintained the domains and motifs for DNA glycosylase activity, which 
include the N-terminal region that is predominantly β-sheet rich and is composed of a β-
sandwich flanked by α-helices. In addition, these proteins retained the C-terminal 
domain, comprising α-helices, two of which form a conserved H2TH motif, as well as 
two anti-parallel β-strands that fold into a zinc finger motif necessary for protein function. 
Overall, the NeiII homologue showed a strong resemblance to previously characterised 
Nei DNA glycosylases in Escherichia coli, Thermus thermophilus, Geobacillus 
stearothermophilus and Lactococcus lactis (Zharkov et al., 2003). In addition, the zinc 
finger and H2TH motifs have been shown to be essential for Nei to bind to DNA. Both 
the M. smegmatis and M. tuberculosis NeiI proteins have maintained the domains and 
motifs required for function, however the M. smegmatis NeiI glycosylase lacks the Fapy 
DNA glycosylase motif. Therefore, from these observations, it is possible that the NeiII 
DNA glycosylase is the more dominant DNA glycosylase during BER as it possesses an 
additional Fapy DNA glycosylase motif. Alternatively, the absence/presence of the Fapy 
DNA glycosylate motif may confer some level of substrate specificity to these enzymes. 
It has been previously shown that most organisms have maintained one member of the 
Nei family of DNA glycosylases but rarely both, suggesting that the retention and 
duplication of these BER enzymes in intracellular organisms, such as M. tuberculosis 
and S. typhimurium, might be a deliberate adaptation that has allowed increased 
survival of these pathogens when exposed to oxidative stress (Suvarnapunya et al., 
2003).  
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In order to identify the individual and/or combined role(s) of the Nei DNA glycosylase 
homologues in mycobacterial DNA repair, double knockout mutant strains that lacked 
the Nth DNA glycosylase in combination with either the NeiI homologue or NeiII 
homologue were generated in M. smegmatis by homologous recombination and 
phenotypically assessed. The resulting phenotypes were compared to the wild type 
strain as well as the single deletion mutant strains that lacked Nth or the respective 
individual Nei homologues. 
Nei DNA glycosylases are non-essential for growth under normal culture 
conditions. 
Comparison of growth kinetics for the parental, single nei and nth deletion mutants and 
double nei/nth deletion mutant strains showed no differences. These results compared 
well to previously published data, where a single ΔneiI, ΔneiII and Δnth deletion mutants 
of M. smegmatis showed no growth defects under normal culture conditions (Goosens, 
2009, Moolla et al., 2014). This observation clearly indicates that these glycosylases are 
not essential for survival. Interestingly, some bacterial species such as H. pylori and 
Haemophilus influenzae do not possess genes that encode for the Nei DNA 
glycosylases (Tomb et al., 1997) suggesting that in M. smegmatis not only the retention 
but the duplication of the Nei DNA glycosylases may be a deliberate evolutionary event 
for the survival of the organism during stressful conditions.  
M. smegmatis strain lacking both Nth and NeiII DNA glycosylases is sensitive to 
hydrogen peroxide treatment. 
Under oxidative stress conditions as generated by 2.0 mM hydrogen peroxide (H2O2) 
the wild type strain showed no significant difference in killing rates compared to the 
untreated cells as measured by CFU/mL. However, variations in killing rates between 
biological replicates was noted which could be due to the decomposition of H2O2, since 
H2O2 spontaneously decomposes into water and oxygen, in a manner dependent on 
temperature, initial concentration and pH (Wilson et al., 2000). Mycobacterial cells also 
contain the catalase enzyme which as mentioned previously, is able to inactivate the 
H2O2 thus providing variable concentrations from one experiment to the next. Although 
  
69 
 
attempts were made to ensure conditions between experiments remained the same, 
there might have been differences in the effective concentration of H2O2 that the cells 
were exposed to between biological replicates.  
To minimise the variation in the effective concentration of H2O2 and to determine the 
appropriate concentration of H2O2 required for killing the M. smegmatis wild type, the 
cells were washes twice as explained  in section 3.5.2 and treated with 1 mM and 2 mM 
concentration of H2O2. The unwashed cells that were treated with 1 mM H2O2 showed 
no difference in killing compared to the washed cells. However, when the same 
unwashed cells were treated with 2 mM H2O2 a slight reduction in survival was observed 
over time. In contrast the cells that were washed showed enhanced killing at both 
concentrations of hydrogen peroxide, with a greater reduction in survival at the 2 mM 
concentration which conferred with previous observations by (Moolla et al., 2014). 
These data indicate that there clearly are components in the spent media that inactivate 
the H2O2, thus reducing its oxidative capacity and resulting in variable outcomes from 
one experiment to the next.  
The single Δnth, ΔneiI and ΔneiII deletion mutants showed no differences in survival 
under when exposed to H2O2 compared to the parental and the respective genetically 
complemented strains. This observation compared well to that observed for the E. coli 
nth and the M. smegmatis neiI and neiII deficient mutants (Cunningham and Weiss, 
1985, Zheng and Zhu, 2003, Goosens, 2009). It is highly likely that survival of the E. coli 
and M. smegmatis strains in the absence of a single DNA glycosylase can be attributed 
to the ability of the remaining DNA glycosylases to compensate for the defect and 
maintain genome integrity under genotoxic conditions. However, in this study when both 
the neiII and nth genes were deleted, the combinatorial mutant displayed an 
exaggerated 3 log reduction in survival under oxidative stress conditions, compared to 
the single nth and neiII mutants suggesting that these two DNA glycosylases in 
combination are important during BER. However, when neiI was inactivated together 
with the nth glycosylase the reduction in growth was marginal (1 log) under oxidative 
stress conditions compared to the single nth and neiI mutants suggesting that the NeiII 
DNA glycosylase is a more dominant player in BER and that NeiI may be serving a 
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backup role. Similarly, E. coli (Zheng and Zhu, 2003) and S. typhimurium 
(Suvarnapunya et al., 2003) mutants deficient in both nei and nth genes displayed 
increased hypersensitivity which was absent in the respective single mutants. These 
data clearly indicate that neiII and nth DNA glycosylases have a major role in BER for 
the repair of damaged DNA under oxidative stress, and in mycobacteria, the NeiII DNA 
glycosylase seems to have a more significant role in genome maintenance compared to 
the NeiI DNA glycosylase.  
The first reported study in mycobacteria that shows functional overlap between two 
DNA repair glycosylases (Nth and Nei) under oxidative stress was by Moolla et al  
(Moolla et al., 2014). In this study, these observations were further interrogated to 
establish if there was any functional hierarchy between the two Nei homologues. Since 
ΔneiI and ΔneiII single mutants did not display any survival defects under oxidative 
stress, it clearly indicates that in these mutant strains of  M. smegmatis the remaining 
nei homologue and more significantly the Nth DNA glycosylase which has been shown 
to have anitmutator properties (Moolla et al., 2014) can compensate for the loss of the 
single Nei glycosylase. It has been biochemically proven that the Nth endonuclease and 
Nei DNA glycosylases have similar substrate specificity (Guo et al., 2010), they mainly 
excise pyrimidine lesions hence, it is highly possible that they have compensatory roles 
(Dizdaroglu, 2003) as generated by H2O2.  
Combinatorial loss of the nth and neiII genes yielded increased mutation rate to 
rifampicin. 
To further investigate the role of the individual Nei homologues in combination with the 
Nth DNA glycosylase, the number of spontaneous mutational events for the various 
single and double mutant strains was measured using the Luria-Delbrück fluctuation 
analysis (mutation rate), which measures the mutational events that occur within a cell 
during its lifetime and excludes pre-existing mutants that result in “jackpots” thus over 
estimating mutations (Rosche and Foster, 2000).  
The single mutants (∆nth, ∆neiI and ∆neiII) displayed only a slight elevation in mutation 
rates compared to the wild type strain. This observation was in contrast to the 
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previously observed mutation phenotypes wherein Moolla et al observed a significant 
increase in mutation rate in the absence of Nth thus identifying it to have antimutator 
properties in the BER pathway (Moolla et al., 2014, Goosens, 2009).  It is possible that 
as these differences could be due to technical variations such as inoculum size, growth 
phase of cells which may have resulted in differences in the total final number of viable 
cells that were plated on rifampicin between the current and previously reported studies.  
However, combinatorial deletion of the nth and nei DNA glycosylases resulted in the 
expected increase in spontaneous mutations with NeiII showing a 6-8 fold increase in 
mutation rates compared to the 2 fold increase observed with the simultaneous deletion 
of NeiI with Nth. This observation also correlated with the earlier observed phenotype of 
the ∆neiII ∆nth mutant being more sensitive to hydrogen peroxide than the ∆nth ∆neiI 
mutant. Thus, these data clearly confirm that NeiII is the major role player during DNA 
repair.  
In conclusion this study provided insights on the relationship between the Nth and 
NeiI/NeiII homologues the base excision repair pathway during repair of damaged 
lesions. Based on the data obtained, it is clear that the loss of Nth and NeiII has a 
greater impact on the survival of M. smegmatis under oxidative stress conditions, 
compared to the combinatorial loss of Nth and NeiI. Therefore, a greater role can be 
assigned to NeiII compared to NeiI in the maintenance of mycobacterial genome 
integrity.  
Limitations of this study 
As hydrogen peroxide is unstable and results in variable experimental outcomes, novel 
robust assay systems are required to assess for DNA damage in mycobacteria. The 
current assays are based on the genetic assessment of the various mutants which, 
provides a crude measurement for genome maintenance based on survival and 
mutation rates. More sophisticated tools need to be developed that can perhaps 
measure specific lesions associated with specific DNA glycosylases in order to assign 
accurate function to them. Development in these areas will certainly intensify our 
understanding of the BER pathway in mycobacterial genome maintenance.   
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Future studies                                                                                                                   
A measure of the expression levels of the remaining DNA glycosylases in the various 
combinatorial deletion mutants under normal culture conditions as well as under 
oxidative stress conditions will confirm and provide new information on the back up 
function of these various DNA glycosylases for genome maintenance. Isolation of 
mycobacterial proteins also presents a hurdle and therefore restricts the biochemical 
assessment of these various DNA glycosylases and their interaction with each other. 
Such confirmatory experiments will allow for better understanding of the role of each of 
the DNA glycosylases in BER and ultimately help delineate the complexities involved in 
the maintenance of the mycobacterial genome integrity under oxidative stress 
conditions.  
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6. Appendices 
Appendix A  
6.1 Media preparation and solutions 
6.1.1 Mycobacterium smegmatis 
 
Middlebrook 7H9 
4.9 g 7H9 powder, 0.2% glycerol, 0.05% Tween 80 (filter sterilized) and 0.2% glucose 
Middlebrook 7H10 
19 g 7H10 powder, 0.085 % NaCl, 0.2 % glucose, 0.2 % glycerol 
 
6.2 Escherichia coli 
2XTY 
5 g sodium chloride, 10 g yeast extract, 16 g tryptone 
Luria-Bertani Broth (LB)  
5 g yeast extract, 10 g tryptone, 10 g NaCl. 
Luria-Bertani Agar (LA) 
5 g yeast, 10 g tryptone, 10 g sodium chloride, 15 g agar 
All media was made up to 1000 mL and autoclaved at 121 ˚C for 10 min. 
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Appendix B 
Lambda DNA molecular weight markers  
 
The above DNA molecular weight markers III and VI used in this study were supplied by 
Roche Applied Science. 
 
Appendix C 
Maps of vectors used in this study 
 
pGEM3ZFm
3199 bps
EcoRI
Ecl136II
SacI
Acc65I
KpnI
AvaI
SmaI
XmaI
BamHI
XbaI
AccI
HincII
SalI
BspMI
SbfI
PstI
SphI
HindIII
SapI
AflIII
PciI
AlwNI
AhdI
BsaI
BpmI
ScaI
XmnI
AatII
ZraI
EcoO109I
BstAPI
NdeI
NaeI
NgoMIV
BsaAI
DraIII
PsiI
bla
lacZ
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Figure 6.1: pGEM3Zf(+).Vector used for cloning upstream and downstream fragments. 
 
Figure 6.2: p2NIL suicide vector. Vector used in 3 way cloning, where the upstream 
and downstream fragments were simultaneously ligated into p2NIL. 
 
Figure 6.3: pGOAL19. Vector with the Pac cassette ( sacB, lacZ, bla and hyg)  which 
was inserted into p2NIL to generate p2NILΔnth::pGOAL19 ( Moolla et al., 2014). 
p2NIL
4753 bps
PmlI
SalI
BamHI
BsrGI
Acc65I
KpnI
SacII
NotI
Eco52I
PacI
EcoRI
BssHII
MluI
OliI
Eco47III
BbvCI
NaeI
NgoMIV
Van91I
SgfI
SspI
EcoNI
ClaI
NruI
AvaI
XhoI
Tth111I
Bst1107I
BstAPI
NdeI
SapI
PciI
BciVI
AlwNI
AhdI
BsaI
BpmI
BglI
PstI
ScaI
BsaHI
XmnI
HindIII
aph
(bla)
pGOAL19
10435 bps
2000
4000
6000
8000
10000
PacI
SalI
PstI
StuI
PstI
ApaI
XbaI
SalI
PstI
SphI
NcoI
XbaI
BglII
PacI
PstI
ScaI
XmnI
sacB
85lacZ
hyg
bla
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Figure 6.4: pTWEETY. Vector used for constructing the complementation vector. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
pTWEETY
5835 bps
PsiI
DraIII
BsaAI
EcoRI
Ecl136II
SacI
Acc65I
KpnI
XbaI
FspAI
BglII
MluI
BssHII
Eco52I
BsaBI
BseRI
BstAPI
MscI
NcoI
SacII
BstBI
SbfI
PstI
XhoI
NruI
EcoNI
SgfI
SapI
AhdI
BsaI
ScaI
XmnI
IntegraseORF-1
ORF-4
KanR
ORF-3
ORF-2
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Appendix D 
Table 6.1: PCR primers used in this study  
Name of 
fragment 
Name of 
primers 
Oligonucleotide 
sequence (5’- 3’) 
Annealing 
temperature 
and DNA 
polymerase 
Amplicon 
properties 
M. smegmatis 
nth  
NthCF AGCTTGACGGTC
TGAAGGACCAGT  
Taq/Phusion = 
63.0 oC 
1150 bp nth 
amplicon 
generated 
from wild type 
M. smegmatis 
genomic DNA 
including 350 
bp upstream of 
the gene.  
NthCR GGTACCCGAGAC
GCTCATCGTGTG  
Us  NthUsF1  AAGCTT  
GTGTGCGTGCTG
GCCAAG  
Taq/Phusion = 
63.5 oC 
1185 bp 
amplicon 
generated 
from wild type 
genomic M. 
smegmatis 
DNA retaining 
100 bp 
upstream of 
the nth gene  
NthUsR1 AGATCT 
CACACCGGTGAT
CGTCTT 
Ds  NthDsF2  AGATCT  
ACGACGCACGAG
ACCCAG  
Taq/Phusion = 
63.5 oC 
1170 bp 
amplicon 
generated 
from the wild 
type M. 
smegmatis nth 
allele retaining 
110 bp 
downstream of 
the gene.  
 NthDsR2 GGTACC 
AGCTGGGCGATC
TCTTCC 
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Table 6.2: Primers used for qPCR 
Name of 
primers 
Oligonucleotide 
sequence (5’- 3’) 
Annealing 
temperature and 
DNA polymerase 
Amplicon 
properties 
RTF1  TTCCTGGCCGAG
CTTGAT  
Taq = 56.5 ˚C Amplification of 
fragment from 
position 135-360 in 
nth  
RTR1  ACAAGCGGGTCA
ACCTGA  
 
SigAF1  GGGCGTGATGTC
CATCTCCT  
Taq = 56.0 ˚C Amplification of 
fragment from 
position 367-488 in 
sigA 
SigAR1  GTATCCCGGTGC
ATGGTC  
 
MutYRT F1 TGGCGCTCGGCC
GGATTCC 
Taq = 60 ˚C Amplification of 
fragment from 
position 102-232 in 
muty 
MutYRT R1 GTCCACCAGCAG
CGAGTC 
 
 
Table 6.3: PCR reagents and cycling conditions 
 
 
